Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0044237 | 0.00000 | 1.85852 | 605 | 823 | 9199 | cellular metabolic process |
| GO:0008152 | 0.00000 | 1.83723 | 680 | 895 | 10337 | metabolic process |
| GO:0006807 | 0.00000 | 1.81578 | 577 | 785 | 8771 | nitrogen compound metabolic process |
| GO:0006518 | 0.00000 | 3.37730 | 50 | 138 | 758 | peptide metabolic process |
| GO:0034641 | 0.00000 | 1.83685 | 357 | 533 | 5435 | cellular nitrogen compound metabolic process |
| GO:1901564 | 0.00000 | 1.77080 | 403 | 578 | 6130 | organonitrogen compound metabolic process |
| GO:0044238 | 0.00000 | 1.71409 | 611 | 801 | 9296 | primary metabolic process |
| GO:0071704 | 0.00000 | 1.70526 | 647 | 836 | 9839 | organic substance metabolic process |
| GO:0043043 | 0.00000 | 3.33811 | 41 | 114 | 626 | peptide biosynthetic process |
| GO:0006412 | 0.00000 | 3.33176 | 40 | 110 | 604 | translation |
| GO:0043603 | 0.00000 | 2.74927 | 64 | 149 | 970 | cellular amide metabolic process |
| GO:1901566 | 0.00000 | 2.30634 | 101 | 201 | 1539 | organonitrogen compound biosynthetic process |
| GO:0043604 | 0.00000 | 2.95138 | 48 | 119 | 723 | amide biosynthetic process |
| GO:0044260 | 0.00000 | 1.66979 | 459 | 624 | 6974 | cellular macromolecule metabolic process |
| GO:0009987 | 0.00000 | 1.73883 | 1026 | 1184 | 15608 | cellular process |
| GO:0071840 | 0.00000 | 1.67996 | 401 | 558 | 6096 | cellular component organization or biogenesis |
| GO:0016043 | 0.00000 | 1.64512 | 390 | 538 | 5929 | cellular component organization |
| GO:0007005 | 0.00000 | 3.38750 | 29 | 83 | 445 | mitochondrion organization |
| GO:0033108 | 0.00000 | 10.43495 | 5 | 31 | 74 | mitochondrial respiratory chain complex assembly |
| GO:0043170 | 0.00000 | 1.57387 | 549 | 705 | 8357 | macromolecule metabolic process |
| GO:0009058 | 0.00000 | 1.65120 | 329 | 464 | 5000 | biosynthetic process |
| GO:1901576 | 0.00000 | 1.64811 | 323 | 456 | 4910 | organic substance biosynthetic process |
| GO:0044249 | 0.00000 | 1.64891 | 317 | 449 | 4824 | cellular biosynthetic process |
| GO:0044267 | 0.00000 | 1.64691 | 295 | 421 | 4494 | cellular protein metabolic process |
| GO:0019538 | 0.00000 | 1.59753 | 346 | 476 | 5268 | protein metabolic process |
| GO:0009205 | 0.00000 | 4.03634 | 17 | 55 | 254 | purine ribonucleoside triphosphate metabolic process |
| GO:0009144 | 0.00000 | 3.95211 | 17 | 56 | 263 | purine nucleoside triphosphate metabolic process |
| GO:0009141 | 0.00000 | 3.81921 | 18 | 58 | 280 | nucleoside triphosphate metabolic process |
| GO:0009199 | 0.00000 | 3.95607 | 17 | 55 | 258 | ribonucleoside triphosphate metabolic process |
| GO:0009123 | 0.00000 | 3.83971 | 18 | 56 | 269 | nucleoside monophosphate metabolic process |
| GO:0044271 | 0.00000 | 1.62930 | 258 | 369 | 3918 | cellular nitrogen compound biosynthetic process |
| GO:0010257 | 0.00000 | 13.73798 | 3 | 21 | 43 | NADH dehydrogenase complex assembly |
| GO:0032981 | 0.00000 | 13.73798 | 3 | 21 | 43 | mitochondrial respiratory chain complex I assembly |
| GO:0046034 | 0.00000 | 4.06937 | 15 | 50 | 229 | ATP metabolic process |
| GO:0009167 | 0.00000 | 3.84528 | 17 | 53 | 254 | purine ribonucleoside monophosphate metabolic process |
| GO:0009126 | 0.00000 | 3.82607 | 17 | 53 | 255 | purine nucleoside monophosphate metabolic process |
| GO:0044085 | 0.00000 | 1.70074 | 193 | 292 | 2940 | cellular component biogenesis |
| GO:0009161 | 0.00000 | 3.76955 | 17 | 53 | 258 | ribonucleoside monophosphate metabolic process |
| GO:0006163 | 0.00000 | 2.96634 | 28 | 72 | 428 | purine nucleotide metabolic process |
| GO:0006753 | 0.00000 | 2.68741 | 36 | 84 | 544 | nucleoside phosphate metabolic process |
| GO:0009150 | 0.00000 | 3.02687 | 26 | 69 | 403 | purine ribonucleotide metabolic process |
| GO:0009117 | 0.00000 | 2.70156 | 35 | 83 | 535 | nucleotide metabolic process |
| GO:0010467 | 0.00000 | 1.56277 | 309 | 424 | 4707 | gene expression |
| GO:0019693 | 0.00000 | 2.89830 | 28 | 71 | 430 | ribose phosphate metabolic process |
| GO:0009259 | 0.00000 | 2.93751 | 27 | 69 | 413 | ribonucleotide metabolic process |
| GO:0009059 | 0.00000 | 1.57075 | 265 | 369 | 4028 | macromolecule biosynthetic process |
| GO:0043933 | 0.00000 | 1.78408 | 126 | 202 | 1910 | protein-containing complex subunit organization |
| GO:0072521 | 0.00000 | 2.70750 | 31 | 73 | 468 | purine-containing compound metabolic process |
| GO:0022607 | 0.00000 | 1.66001 | 179 | 267 | 2723 | cellular component assembly |
| GO:0034622 | 0.00000 | 2.09871 | 65 | 122 | 984 | cellular protein-containing complex assembly |
| GO:0055086 | 0.00000 | 2.40523 | 40 | 85 | 604 | nucleobase-containing small molecule metabolic process |
| GO:0042775 | 0.00000 | 8.39001 | 4 | 21 | 57 | mitochondrial ATP synthesis coupled electron transport |
| GO:0006139 | 0.00000 | 1.49675 | 310 | 413 | 4720 | nucleobase-containing compound metabolic process |
| GO:0065003 | 0.00000 | 1.78640 | 111 | 180 | 1690 | protein-containing complex assembly |
| GO:0034645 | 0.00000 | 1.52763 | 259 | 354 | 3933 | cellular macromolecule biosynthetic process |
| GO:0006725 | 0.00000 | 1.48390 | 323 | 426 | 4913 | cellular aromatic compound metabolic process |
| GO:0046483 | 0.00000 | 1.47952 | 319 | 420 | 4848 | heterocycle metabolic process |
| GO:0042773 | 0.00000 | 7.54962 | 4 | 21 | 61 | ATP synthesis coupled electron transport |
| GO:1901135 | 0.00000 | 2.01566 | 62 | 114 | 949 | carbohydrate derivative metabolic process |
| GO:0019637 | 0.00000 | 2.02392 | 60 | 111 | 920 | organophosphate metabolic process |
| GO:0006119 | 0.00000 | 5.53918 | 6 | 25 | 90 | oxidative phosphorylation |
| GO:1901360 | 0.00000 | 1.45038 | 335 | 434 | 5097 | organic cyclic compound metabolic process |
| GO:0022900 | 0.00000 | 5.57198 | 6 | 24 | 86 | electron transport chain |
| GO:0044281 | 0.00000 | 1.70246 | 112 | 175 | 1708 | small molecule metabolic process |
| GO:0001558 | 0.00000 | 2.48721 | 28 | 63 | 432 | regulation of cell growth |
| GO:0055114 | 0.00000 | 1.94672 | 62 | 110 | 942 | oxidation-reduction process |
| GO:0022904 | 0.00000 | 5.45366 | 5 | 22 | 80 | respiratory electron transport chain |
| GO:0006996 | 0.00000 | 1.48206 | 230 | 310 | 3492 | organelle organization |
| GO:0010499 | 0.00000 | 14.31332 | 2 | 12 | 24 | proteasomal ubiquitin-independent protein catabolic process |
| GO:0006120 | 0.00000 | 17.48495 | 1 | 11 | 20 | mitochondrial electron transport, NADH to ubiquinone |
| GO:0017144 | 0.00000 | 2.07002 | 46 | 86 | 694 | drug metabolic process |
| GO:0042254 | 0.00000 | 2.79711 | 18 | 45 | 278 | ribosome biogenesis |
| GO:0048519 | 0.00000 | 1.39612 | 341 | 430 | 5186 | negative regulation of biological process |
| GO:0043067 | 0.00000 | 1.68164 | 101 | 156 | 1531 | regulation of programmed cell death |
| GO:0016049 | 0.00000 | 2.22578 | 34 | 68 | 513 | cell growth |
| GO:0010941 | 0.00000 | 1.64155 | 110 | 167 | 1677 | regulation of cell death |
| GO:0045333 | 0.00000 | 3.54749 | 10 | 31 | 157 | cellular respiration |
| GO:0012501 | 0.00000 | 1.59725 | 125 | 184 | 1898 | programmed cell death |
| GO:0042981 | 0.00000 | 1.65300 | 99 | 152 | 1512 | regulation of apoptotic process |
| GO:0008219 | 0.00000 | 1.56034 | 135 | 195 | 2056 | cell death |
| GO:0051179 | 0.00000 | 1.36279 | 381 | 469 | 5794 | localization |
| GO:0006915 | 0.00000 | 1.58108 | 122 | 179 | 1860 | apoptotic process |
| GO:0006796 | 0.00000 | 1.47070 | 190 | 258 | 2893 | phosphate-containing compound metabolic process |
| GO:0000028 | 0.00000 | 14.29578 | 1 | 10 | 20 | ribosomal small subunit assembly |
| GO:0006974 | 0.00000 | 1.94654 | 47 | 84 | 714 | cellular response to DNA damage stimulus |
| GO:0048523 | 0.00000 | 1.38038 | 303 | 382 | 4605 | negative regulation of cellular process |
| GO:0006793 | 0.00000 | 1.45746 | 192 | 258 | 2914 | phosphorus metabolic process |
| GO:0060548 | 0.00000 | 1.73755 | 70 | 113 | 1067 | negative regulation of cell death |
| GO:0022613 | 0.00000 | 2.23108 | 28 | 56 | 420 | ribonucleoprotein complex biogenesis |
| GO:0006950 | 0.00000 | 1.40700 | 231 | 300 | 3512 | response to stress |
| GO:0009966 | 0.00000 | 1.45021 | 178 | 240 | 2712 | regulation of signal transduction |
| GO:0006091 | 0.00000 | 2.32522 | 23 | 49 | 354 | generation of precursor metabolites and energy |
| GO:0032543 | 0.00000 | 4.78079 | 5 | 18 | 72 | mitochondrial translation |
| GO:0042255 | 0.00000 | 4.78079 | 5 | 18 | 72 | ribosome assembly |
| GO:0006364 | 0.00000 | 2.95557 | 12 | 32 | 188 | rRNA processing |
| GO:0018158 | 0.00000 | 19.03947 | 1 | 8 | 14 | protein oxidation |
| GO:0043069 | 0.00000 | 1.73634 | 63 | 102 | 961 | negative regulation of programmed cell death |
| GO:0051247 | 0.00000 | 1.55235 | 106 | 154 | 1616 | positive regulation of protein metabolic process |
| GO:0065002 | 0.00000 | 5.37120 | 4 | 15 | 55 | intracellular protein transmembrane transport |
| GO:0097190 | 0.00000 | 1.92991 | 39 | 70 | 597 | apoptotic signaling pathway |
| GO:0071806 | 0.00000 | 5.23995 | 4 | 15 | 56 | protein transmembrane transport |
| GO:0016072 | 0.00000 | 2.66253 | 14 | 34 | 218 | rRNA metabolic process |
| GO:0009888 | 0.00000 | 1.49951 | 125 | 175 | 1899 | tissue development |
| GO:0001944 | 0.00000 | 1.80873 | 49 | 82 | 742 | vasculature development |
| GO:0009124 | 0.00000 | 3.05711 | 10 | 27 | 154 | nucleoside monophosphate biosynthetic process |
| GO:0042274 | 0.00000 | 4.77579 | 4 | 16 | 64 | ribosomal small subunit biogenesis |
| GO:0072593 | 0.00000 | 2.41508 | 18 | 40 | 279 | reactive oxygen species metabolic process |
| GO:0072358 | 0.00000 | 1.79832 | 50 | 83 | 755 | cardiovascular system development |
| GO:0002181 | 0.00000 | 4.00749 | 6 | 19 | 87 | cytoplasmic translation |
| GO:0072522 | 0.00000 | 2.58664 | 15 | 35 | 230 | purine-containing compound biosynthetic process |
| GO:0009142 | 0.00000 | 3.11455 | 10 | 26 | 146 | nucleoside triphosphate biosynthetic process |
| GO:0051239 | 0.00000 | 1.38372 | 209 | 269 | 3173 | regulation of multicellular organismal process |
| GO:0140053 | 0.00000 | 3.72627 | 6 | 20 | 97 | mitochondrial gene expression |
| GO:0009967 | 0.00000 | 1.54913 | 97 | 141 | 1478 | positive regulation of signal transduction |
| GO:0072359 | 0.00000 | 1.63302 | 73 | 112 | 1115 | circulatory system development |
| GO:0016310 | 0.00000 | 1.45472 | 141 | 192 | 2144 | phosphorylation |
| GO:0043066 | 0.00000 | 1.68812 | 62 | 98 | 945 | negative regulation of apoptotic process |
| GO:0006164 | 0.00000 | 2.56411 | 15 | 34 | 225 | purine nucleotide biosynthetic process |
| GO:0001503 | 0.00000 | 2.16115 | 24 | 48 | 369 | ossification |
| GO:0009206 | 0.00000 | 3.19193 | 9 | 24 | 132 | purine ribonucleoside triphosphate biosynthetic process |
| GO:0051246 | 0.00001 | 1.40988 | 174 | 229 | 2642 | regulation of protein metabolic process |
| GO:0009152 | 0.00001 | 2.63236 | 14 | 32 | 207 | purine ribonucleotide biosynthetic process |
| GO:0009145 | 0.00001 | 3.16250 | 9 | 24 | 133 | purine nucleoside triphosphate biosynthetic process |
| GO:0051186 | 0.00001 | 1.98566 | 32 | 58 | 481 | cofactor metabolic process |
| GO:0048583 | 0.00001 | 1.34949 | 247 | 310 | 3755 | regulation of response to stimulus |
| GO:0051128 | 0.00001 | 1.41610 | 165 | 219 | 2513 | regulation of cellular component organization |
| GO:0009394 | 0.00001 | 7.93917 | 2 | 10 | 28 | 2'-deoxyribonucleotide metabolic process |
| GO:0019692 | 0.00001 | 7.93917 | 2 | 10 | 28 | deoxyribose phosphate metabolic process |
| GO:0009127 | 0.00001 | 3.04377 | 9 | 25 | 143 | purine nucleoside monophosphate biosynthetic process |
| GO:0009168 | 0.00001 | 3.04377 | 9 | 25 | 143 | purine ribonucleoside monophosphate biosynthetic process |
| GO:0090407 | 0.00001 | 1.98357 | 31 | 57 | 473 | organophosphate biosynthetic process |
| GO:0009201 | 0.00001 | 3.10523 | 9 | 24 | 135 | ribonucleoside triphosphate biosynthetic process |
| GO:0006508 | 0.00001 | 1.50565 | 108 | 152 | 1636 | proteolysis |
| GO:0090304 | 0.00001 | 1.32981 | 276 | 341 | 4198 | nucleic acid metabolic process |
| GO:0051270 | 0.00001 | 1.65193 | 65 | 101 | 993 | regulation of cellular component movement |
| GO:0071702 | 0.00001 | 1.41431 | 161 | 213 | 2444 | organic substance transport |
| GO:0009132 | 0.00001 | 3.34764 | 7 | 21 | 111 | nucleoside diphosphate metabolic process |
| GO:0006810 | 0.00001 | 1.32073 | 283 | 347 | 4298 | transport |
| GO:0009156 | 0.00001 | 2.94343 | 10 | 25 | 147 | ribonucleoside monophosphate biosynthetic process |
| GO:0034470 | 0.00001 | 2.16736 | 22 | 44 | 337 | ncRNA processing |
| GO:0051234 | 0.00001 | 1.31580 | 291 | 356 | 4428 | establishment of localization |
| GO:2001233 | 0.00001 | 2.04095 | 27 | 50 | 404 | regulation of apoptotic signaling pathway |
| GO:0015980 | 0.00001 | 2.38871 | 16 | 35 | 246 | energy derivation by oxidation of organic compounds |
| GO:0040008 | 0.00001 | 1.73895 | 49 | 79 | 739 | regulation of growth |
| GO:0009260 | 0.00001 | 2.50256 | 14 | 32 | 216 | ribonucleotide biosynthetic process |
| GO:0045184 | 0.00001 | 1.46375 | 119 | 164 | 1812 | establishment of protein localization |
| GO:0032270 | 0.00001 | 1.50702 | 99 | 141 | 1513 | positive regulation of cellular protein metabolic process |
| GO:0006839 | 0.00001 | 2.75178 | 11 | 27 | 168 | mitochondrial transport |
| GO:0043281 | 0.00001 | 2.58356 | 13 | 30 | 197 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0006928 | 0.00001 | 1.44820 | 127 | 173 | 1932 | movement of cell or subcellular component |
| GO:0034404 | 0.00001 | 2.80843 | 10 | 26 | 159 | nucleobase-containing small molecule biosynthetic process |
| GO:0031214 | 0.00002 | 2.87239 | 10 | 25 | 150 | biomineral tissue development |
| GO:0009165 | 0.00002 | 2.29747 | 18 | 37 | 269 | nucleotide biosynthetic process |
| GO:0001568 | 0.00002 | 1.74007 | 47 | 76 | 710 | blood vessel development |
| GO:1990542 | 0.00002 | 4.21057 | 4 | 15 | 66 | mitochondrial transmembrane transport |
| GO:1902600 | 0.00002 | 3.58262 | 6 | 18 | 90 | proton transmembrane transport |
| GO:0008625 | 0.00002 | 3.95056 | 5 | 16 | 74 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0043062 | 0.00002 | 2.22146 | 19 | 39 | 292 | extracellular structure organization |
| GO:0042451 | 0.00002 | 9.51711 | 1 | 8 | 20 | purine nucleoside biosynthetic process |
| GO:0046129 | 0.00002 | 9.51711 | 1 | 8 | 20 | purine ribonucleoside biosynthetic process |
| GO:0030307 | 0.00002 | 2.57341 | 13 | 29 | 191 | positive regulation of cell growth |
| GO:0015031 | 0.00002 | 1.46432 | 112 | 155 | 1709 | protein transport |
| GO:0032268 | 0.00002 | 1.39056 | 161 | 211 | 2454 | regulation of cellular protein metabolic process |
| GO:0040007 | 0.00002 | 1.57851 | 73 | 108 | 1106 | growth |
| GO:2000145 | 0.00002 | 1.63845 | 60 | 92 | 909 | regulation of cell motility |
| GO:0015988 | 0.00002 | 6.49449 | 2 | 10 | 32 | energy coupled proton transmembrane transport, against electrochemical gradient |
| GO:0046390 | 0.00003 | 2.41006 | 15 | 32 | 223 | ribose phosphate biosynthetic process |
| GO:0032879 | 0.00003 | 1.36510 | 181 | 232 | 2749 | regulation of localization |
| GO:0050793 | 0.00003 | 1.36919 | 176 | 227 | 2681 | regulation of developmental process |
| GO:0044743 | 0.00003 | 5.61524 | 3 | 11 | 39 | protein transmembrane import into intracellular organelle |
| GO:0040017 | 0.00003 | 1.80641 | 38 | 64 | 577 | positive regulation of locomotion |
| GO:1901293 | 0.00003 | 2.22945 | 18 | 37 | 276 | nucleoside phosphate biosynthetic process |
| GO:0044283 | 0.00003 | 1.77767 | 40 | 67 | 613 | small molecule biosynthetic process |
| GO:0033036 | 0.00003 | 1.35887 | 185 | 237 | 2821 | macromolecule localization |
| GO:0048870 | 0.00003 | 1.47823 | 101 | 141 | 1538 | cell motility |
| GO:0051674 | 0.00003 | 1.47823 | 101 | 141 | 1538 | localization of cell |
| GO:0015985 | 0.00003 | 8.78462 | 1 | 8 | 21 | energy coupled proton transport, down electrochemical gradient |
| GO:0015986 | 0.00003 | 8.78462 | 1 | 8 | 21 | ATP synthesis coupled proton transport |
| GO:0009262 | 0.00003 | 6.21183 | 2 | 10 | 33 | deoxyribonucleotide metabolic process |
| GO:0090101 | 0.00003 | 3.15096 | 7 | 20 | 111 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0006396 | 0.00004 | 1.66265 | 53 | 83 | 808 | RNA processing |
| GO:0042246 | 0.00004 | 4.53530 | 4 | 13 | 54 | tissue regeneration |
| GO:0030198 | 0.00004 | 2.28609 | 16 | 34 | 248 | extracellular matrix organization |
| GO:0008283 | 0.00004 | 1.41551 | 130 | 174 | 1981 | cell proliferation |
| GO:0015833 | 0.00004 | 1.43938 | 116 | 157 | 1757 | peptide transport |
| GO:0051272 | 0.00004 | 1.79779 | 37 | 62 | 561 | positive regulation of cellular component movement |
| GO:0033554 | 0.00004 | 1.44688 | 111 | 152 | 1692 | cellular response to stress |
| GO:0040012 | 0.00004 | 1.58764 | 65 | 97 | 986 | regulation of locomotion |
| GO:0072655 | 0.00004 | 3.47827 | 6 | 17 | 87 | establishment of protein localization to mitochondrion |
| GO:0051241 | 0.00005 | 1.50569 | 86 | 122 | 1305 | negative regulation of multicellular organismal process |
| GO:0030334 | 0.00005 | 1.62662 | 57 | 87 | 864 | regulation of cell migration |
| GO:0006626 | 0.00005 | 3.83374 | 5 | 15 | 71 | protein targeting to mitochondrion |
| GO:0042886 | 0.00005 | 1.43315 | 117 | 158 | 1775 | amide transport |
| GO:0071705 | 0.00005 | 1.40108 | 137 | 181 | 2081 | nitrogen compound transport |
| GO:0007007 | 0.00005 | 6.76442 | 2 | 9 | 28 | inner mitochondrial membrane organization |
| GO:0015991 | 0.00005 | 6.76442 | 2 | 9 | 28 | ATP hydrolysis coupled proton transport |
| GO:1990748 | 0.00005 | 6.76442 | 2 | 9 | 28 | cellular detoxification |
| GO:0016477 | 0.00005 | 1.48661 | 92 | 129 | 1397 | cell migration |
| GO:0022618 | 0.00005 | 2.34557 | 15 | 31 | 221 | ribonucleoprotein complex assembly |
| GO:0031099 | 0.00005 | 2.84268 | 9 | 22 | 133 | regeneration |
| GO:0045039 | 0.00006 | 23.75575 | 1 | 5 | 8 | protein import into mitochondrial inner membrane |
| GO:0048513 | 0.00006 | 1.31574 | 226 | 279 | 3430 | animal organ development |
| GO:0006749 | 0.00006 | 4.63681 | 3 | 12 | 49 | glutathione metabolic process |
| GO:2000147 | 0.00006 | 1.78876 | 36 | 60 | 545 | positive regulation of cell motility |
| GO:0043068 | 0.00006 | 1.73688 | 41 | 66 | 616 | positive regulation of programmed cell death |
| GO:0048646 | 0.00006 | 1.53179 | 75 | 108 | 1135 | anatomical structure formation involved in morphogenesis |
| GO:0071826 | 0.00007 | 2.27765 | 15 | 32 | 234 | ribonucleoprotein complex subunit organization |
| GO:0001836 | 0.00008 | 4.13140 | 4 | 13 | 58 | release of cytochrome c from mitochondria |
| GO:0030335 | 0.00008 | 1.79094 | 35 | 58 | 526 | positive regulation of cell migration |
| GO:0051240 | 0.00008 | 1.40523 | 124 | 165 | 1887 | positive regulation of multicellular organismal process |
| GO:0042127 | 0.00008 | 1.43371 | 108 | 146 | 1636 | regulation of cell proliferation |
| GO:0008637 | 0.00008 | 3.02481 | 7 | 19 | 109 | apoptotic mitochondrial changes |
| GO:0043065 | 0.00008 | 1.72549 | 40 | 65 | 610 | positive regulation of apoptotic process |
| GO:0010952 | 0.00009 | 2.60868 | 10 | 24 | 156 | positive regulation of peptidase activity |
| GO:0006613 | 0.00009 | 9.07896 | 1 | 7 | 18 | cotranslational protein targeting to membrane |
| GO:0042060 | 0.00009 | 1.99694 | 23 | 42 | 345 | wound healing |
| GO:0018057 | 0.00009 | 56.98163 | 0 | 4 | 5 | peptidyl-lysine oxidation |
| GO:0040011 | 0.00009 | 1.41836 | 115 | 154 | 1744 | locomotion |
| GO:0017004 | 0.00009 | 6.11963 | 2 | 9 | 30 | cytochrome complex assembly |
| GO:0090662 | 0.00009 | 6.11963 | 2 | 9 | 30 | ATP hydrolysis coupled transmembrane transport |
| GO:0099131 | 0.00009 | 6.11963 | 2 | 9 | 30 | ATP hydrolysis coupled ion transmembrane transport |
| GO:0099132 | 0.00009 | 6.11963 | 2 | 9 | 30 | ATP hydrolysis coupled cation transmembrane transport |
| GO:0097193 | 0.00009 | 2.09633 | 19 | 37 | 291 | intrinsic apoptotic signaling pathway |
| GO:0070585 | 0.00009 | 3.24564 | 6 | 17 | 92 | protein localization to mitochondrion |
| GO:0006605 | 0.00010 | 2.19663 | 16 | 33 | 249 | protein targeting |
| GO:0030099 | 0.00010 | 1.91662 | 26 | 46 | 392 | myeloid cell differentiation |
| GO:0010950 | 0.00010 | 2.63909 | 10 | 23 | 148 | positive regulation of endopeptidase activity |
| GO:0048514 | 0.00010 | 1.71259 | 40 | 65 | 614 | blood vessel morphogenesis |
| GO:2001235 | 0.00011 | 2.45521 | 12 | 26 | 178 | positive regulation of apoptotic signaling pathway |
| GO:1901575 | 0.00011 | 1.40519 | 118 | 157 | 1793 | organic substance catabolic process |
| GO:0051171 | 0.00011 | 1.25908 | 329 | 388 | 5008 | regulation of nitrogen compound metabolic process |
| GO:2000116 | 0.00012 | 2.26839 | 14 | 30 | 220 | regulation of cysteine-type endopeptidase activity |
| GO:0008630 | 0.00012 | 2.92683 | 7 | 19 | 112 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0050727 | 0.00013 | 2.01200 | 21 | 39 | 318 | regulation of inflammatory response |
| GO:0006754 | 0.00013 | 2.80972 | 8 | 20 | 122 | ATP biosynthetic process |
| GO:0023051 | 0.00014 | 1.30258 | 215 | 265 | 3277 | regulation of signaling |
| GO:0008104 | 0.00014 | 1.34054 | 165 | 209 | 2504 | protein localization |
| GO:0006954 | 0.00015 | 1.67373 | 42 | 67 | 646 | inflammatory response |
| GO:0046033 | 0.00015 | 10.69465 | 1 | 6 | 14 | AMP metabolic process |
| GO:0010942 | 0.00016 | 1.65548 | 44 | 69 | 672 | positive regulation of cell death |
| GO:1901342 | 0.00016 | 1.97185 | 22 | 40 | 332 | regulation of vasculature development |
| GO:0030199 | 0.00016 | 4.08387 | 4 | 12 | 54 | collagen fibril organization |
| GO:0001525 | 0.00017 | 1.76014 | 33 | 55 | 506 | angiogenesis |
| GO:0052547 | 0.00019 | 1.85661 | 26 | 46 | 403 | regulation of peptidase activity |
| GO:0048584 | 0.00019 | 1.35066 | 147 | 188 | 2231 | positive regulation of response to stimulus |
| GO:2000026 | 0.00019 | 1.35789 | 140 | 181 | 2136 | regulation of multicellular organismal development |
| GO:0030512 | 0.00019 | 3.71740 | 4 | 13 | 63 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0046128 | 0.00019 | 3.98871 | 4 | 12 | 55 | purine ribonucleoside metabolic process |
| GO:0032101 | 0.00020 | 1.61795 | 48 | 73 | 726 | regulation of response to external stimulus |
| GO:0046456 | 0.00020 | 4.76087 | 3 | 10 | 40 | icosanoid biosynthetic process |
| GO:0010646 | 0.00021 | 1.29375 | 214 | 262 | 3256 | regulation of cell communication |
| GO:0048585 | 0.00022 | 1.41122 | 103 | 138 | 1565 | negative regulation of response to stimulus |
| GO:0097435 | 0.00023 | 1.63875 | 44 | 68 | 668 | supramolecular fiber organization |
| GO:2001244 | 0.00023 | 3.64434 | 4 | 13 | 64 | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0045595 | 0.00023 | 1.37495 | 123 | 161 | 1874 | regulation of cell differentiation |
| GO:0045862 | 0.00024 | 1.96624 | 21 | 38 | 316 | positive regulation of proteolysis |
| GO:0006790 | 0.00024 | 2.07985 | 17 | 33 | 261 | sulfur compound metabolic process |
| GO:0009653 | 0.00024 | 1.31797 | 174 | 218 | 2652 | anatomical structure morphogenesis |
| GO:0009163 | 0.00025 | 6.00886 | 2 | 8 | 27 | nucleoside biosynthetic process |
| GO:0042455 | 0.00025 | 6.00886 | 2 | 8 | 27 | ribonucleoside biosynthetic process |
| GO:0010269 | 0.00025 | 28.48950 | 0 | 4 | 6 | response to selenium ion |
| GO:0034112 | 0.00025 | 28.48950 | 0 | 4 | 6 | positive regulation of homotypic cell-cell adhesion |
| GO:0023056 | 0.00026 | 1.37693 | 120 | 157 | 1824 | positive regulation of signaling |
| GO:0030162 | 0.00026 | 1.61711 | 46 | 70 | 696 | regulation of proteolysis |
| GO:0009135 | 0.00027 | 3.05270 | 6 | 16 | 91 | purine nucleoside diphosphate metabolic process |
| GO:0009179 | 0.00027 | 3.05270 | 6 | 16 | 91 | purine ribonucleoside diphosphate metabolic process |
| GO:1903845 | 0.00027 | 3.57409 | 4 | 13 | 65 | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:1902533 | 0.00027 | 1.50876 | 66 | 94 | 998 | positive regulation of intracellular signal transduction |
| GO:0019371 | 0.00028 | Inf | 0 | 3 | 3 | cyclooxygenase pathway |
| GO:0006140 | 0.00031 | 3.01239 | 6 | 16 | 92 | regulation of nucleotide metabolic process |
| GO:0010647 | 0.00031 | 1.37161 | 120 | 156 | 1818 | positive regulation of cell communication |
| GO:0009056 | 0.00031 | 1.34148 | 143 | 182 | 2170 | catabolic process |
| GO:0022603 | 0.00032 | 1.48784 | 69 | 98 | 1054 | regulation of anatomical structure morphogenesis |
| GO:0045766 | 0.00032 | 2.31322 | 12 | 25 | 180 | positive regulation of angiogenesis |
| GO:0009893 | 0.00033 | 1.27746 | 224 | 271 | 3406 | positive regulation of metabolic process |
| GO:0044248 | 0.00034 | 1.35953 | 126 | 163 | 1916 | cellular catabolic process |
| GO:0019438 | 0.00034 | 1.27935 | 219 | 265 | 3324 | aromatic compound biosynthetic process |
| GO:0031589 | 0.00035 | 1.92416 | 21 | 38 | 322 | cell-substrate adhesion |
| GO:2001241 | 0.00036 | 8.55493 | 1 | 6 | 16 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0018130 | 0.00036 | 1.27837 | 218 | 264 | 3313 | heterocycle biosynthetic process |
| GO:0001667 | 0.00036 | 1.80987 | 26 | 45 | 403 | ameboidal-type cell migration |
| GO:0009119 | 0.00037 | 3.44140 | 4 | 13 | 67 | ribonucleoside metabolic process |
| GO:0042278 | 0.00039 | 3.64857 | 4 | 12 | 59 | purine nucleoside metabolic process |
| GO:0048731 | 0.00039 | 1.24126 | 305 | 357 | 4638 | system development |
| GO:1901362 | 0.00040 | 1.27184 | 226 | 273 | 3444 | organic cyclic compound biosynthetic process |
| GO:0048856 | 0.00043 | 1.22234 | 376 | 431 | 5712 | anatomical structure development |
| GO:0051649 | 0.00043 | 1.35589 | 123 | 159 | 1872 | establishment of localization in cell |
| GO:0007006 | 0.00044 | 2.89760 | 6 | 16 | 95 | mitochondrial membrane organization |
| GO:0009185 | 0.00044 | 2.89760 | 6 | 16 | 95 | ribonucleoside diphosphate metabolic process |
| GO:0006281 | 0.00045 | 1.75473 | 29 | 48 | 442 | DNA repair |
| GO:1903706 | 0.00047 | 1.79911 | 26 | 44 | 396 | regulation of hemopoiesis |
| GO:0001934 | 0.00047 | 1.48661 | 65 | 92 | 989 | positive regulation of protein phosphorylation |
| GO:0001954 | 0.00047 | 3.83250 | 3 | 11 | 52 | positive regulation of cell-matrix adhesion |
| GO:1902531 | 0.00047 | 1.37134 | 111 | 145 | 1687 | regulation of intracellular signal transduction |
| GO:0009611 | 0.00048 | 1.71703 | 31 | 51 | 479 | response to wounding |
| GO:2001021 | 0.00049 | 3.31819 | 5 | 13 | 69 | negative regulation of response to DNA damage stimulus |
| GO:0098869 | 0.00050 | 6.24034 | 2 | 7 | 23 | cellular oxidant detoxification |
| GO:0043280 | 0.00051 | 2.65619 | 8 | 18 | 115 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0006614 | 0.00053 | 7.77685 | 1 | 6 | 17 | SRP-dependent cotranslational protein targeting to membrane |
| GO:0007167 | 0.00053 | 1.51569 | 57 | 82 | 865 | enzyme linked receptor protein signaling pathway |
| GO:0019220 | 0.00054 | 1.36958 | 109 | 143 | 1665 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00055 | 1.36861 | 110 | 143 | 1666 | regulation of phosphorus metabolic process |
| GO:0090199 | 0.00056 | 4.07980 | 3 | 10 | 45 | regulation of release of cytochrome c from mitochondria |
| GO:2001242 | 0.00056 | 2.30497 | 11 | 23 | 166 | regulation of intrinsic apoptotic signaling pathway |
| GO:0035239 | 0.00056 | 1.50491 | 59 | 84 | 892 | tube morphogenesis |
| GO:0051173 | 0.00056 | 1.27944 | 197 | 240 | 3000 | positive regulation of nitrogen compound metabolic process |
| GO:0032760 | 0.00058 | 2.93864 | 6 | 15 | 88 | positive regulation of tumor necrosis factor production |
| GO:1900542 | 0.00058 | 2.93864 | 6 | 15 | 88 | regulation of purine nucleotide metabolic process |
| GO:0032502 | 0.00058 | 1.21180 | 401 | 456 | 6097 | developmental process |
| GO:0042325 | 0.00059 | 1.38473 | 99 | 131 | 1508 | regulation of phosphorylation |
| GO:1904018 | 0.00059 | 2.16771 | 13 | 26 | 198 | positive regulation of vasculature development |
| GO:0007275 | 0.00060 | 1.22232 | 344 | 396 | 5227 | multicellular organism development |
| GO:0034655 | 0.00061 | 1.77349 | 26 | 44 | 401 | nucleobase-containing compound catabolic process |
| GO:0044265 | 0.00063 | 1.47803 | 64 | 90 | 972 | cellular macromolecule catabolic process |
| GO:0031323 | 0.00065 | 1.21981 | 348 | 400 | 5290 | regulation of cellular metabolic process |
| GO:0090150 | 0.00065 | 2.11610 | 14 | 27 | 210 | establishment of protein localization to membrane |
| GO:1903557 | 0.00066 | 2.89880 | 6 | 15 | 89 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0030282 | 0.00067 | 2.67300 | 7 | 17 | 108 | bone mineralization |
| GO:0010648 | 0.00067 | 1.40668 | 86 | 116 | 1314 | negative regulation of cell communication |
| GO:0051641 | 0.00069 | 1.29636 | 166 | 205 | 2523 | cellular localization |
| GO:1901659 | 0.00069 | 4.96293 | 2 | 8 | 31 | glycosyl compound biosynthetic process |
| GO:1901137 | 0.00071 | 1.63378 | 37 | 57 | 560 | carbohydrate derivative biosynthetic process |
| GO:0045765 | 0.00072 | 1.89718 | 20 | 35 | 300 | regulation of angiogenesis |
| GO:0045637 | 0.00075 | 2.09303 | 14 | 27 | 212 | regulation of myeloid cell differentiation |
| GO:0023057 | 0.00075 | 1.40173 | 87 | 116 | 1318 | negative regulation of signaling |
| GO:0046907 | 0.00075 | 1.37765 | 98 | 129 | 1491 | intracellular transport |
| GO:0090288 | 0.00077 | 2.40644 | 9 | 20 | 139 | negative regulation of cellular response to growth factor stimulus |
| GO:0009057 | 0.00077 | 1.42481 | 77 | 105 | 1174 | macromolecule catabolic process |
| GO:0098754 | 0.00079 | 4.28196 | 3 | 9 | 39 | detoxification |
| GO:0051093 | 0.00081 | 1.44878 | 69 | 95 | 1045 | negative regulation of developmental process |
| GO:2000377 | 0.00084 | 2.14581 | 13 | 25 | 192 | regulation of reactive oxygen species metabolic process |
| GO:0034660 | 0.00084 | 1.69764 | 30 | 48 | 455 | ncRNA metabolic process |
| GO:0010604 | 0.00086 | 1.26282 | 207 | 249 | 3149 | positive regulation of macromolecule metabolic process |
| GO:0034654 | 0.00089 | 1.25816 | 214 | 256 | 3250 | nucleobase-containing compound biosynthetic process |
| GO:0042326 | 0.00093 | 1.69943 | 29 | 47 | 445 | negative regulation of phosphorylation |
| GO:0042273 | 0.00097 | 2.90035 | 5 | 14 | 83 | ribosomal large subunit biogenesis |
| GO:0051248 | 0.00100 | 1.43770 | 69 | 95 | 1052 | negative regulation of protein metabolic process |
| GO:0006465 | 0.00101 | 8.90635 | 1 | 5 | 13 | signal peptide processing |
| GO:0009219 | 0.00101 | 8.90635 | 1 | 5 | 13 | pyrimidine deoxyribonucleotide metabolic process |
| GO:1901070 | 0.00101 | 8.90635 | 1 | 5 | 13 | guanosine-containing compound biosynthetic process |
| GO:0051094 | 0.00101 | 1.36365 | 100 | 130 | 1516 | positive regulation of developmental process |
| GO:0080090 | 0.00101 | 1.21236 | 338 | 388 | 5147 | regulation of primary metabolic process |
| GO:0052548 | 0.00102 | 1.82029 | 22 | 37 | 329 | regulation of endopeptidase activity |
| GO:0001932 | 0.00102 | 1.37841 | 92 | 121 | 1396 | regulation of protein phosphorylation |
| GO:0035295 | 0.00103 | 1.42587 | 73 | 99 | 1105 | tube development |
| GO:0019222 | 0.00105 | 1.20274 | 384 | 435 | 5833 | regulation of metabolic process |
| GO:0009133 | 0.00105 | 14.24344 | 1 | 4 | 8 | nucleoside diphosphate biosynthetic process |
| GO:0034475 | 0.00105 | 14.24344 | 1 | 4 | 8 | U4 snRNA 3'-end processing |
| GO:0010562 | 0.00106 | 1.42439 | 73 | 99 | 1106 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00106 | 1.42439 | 73 | 99 | 1106 | positive regulation of phosphate metabolic process |
| GO:0009968 | 0.00106 | 1.40955 | 78 | 105 | 1185 | negative regulation of signal transduction |
| GO:0090092 | 0.00107 | 2.00769 | 15 | 28 | 228 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0097191 | 0.00107 | 2.00769 | 15 | 28 | 228 | extrinsic apoptotic signaling pathway |
| GO:0009136 | 0.00108 | 42.70820 | 0 | 3 | 4 | purine nucleoside diphosphate biosynthetic process |
| GO:0009180 | 0.00108 | 42.70820 | 0 | 3 | 4 | purine ribonucleoside diphosphate biosynthetic process |
| GO:0046351 | 0.00108 | 42.70820 | 0 | 3 | 4 | disaccharide biosynthetic process |
| GO:0097250 | 0.00108 | 42.70820 | 0 | 3 | 4 | mitochondrial respiratory chain supercomplex assembly |
| GO:0110096 | 0.00108 | 42.70820 | 0 | 3 | 4 | cellular response to aldehyde |
| GO:0006220 | 0.00108 | 4.56547 | 2 | 8 | 33 | pyrimidine nucleotide metabolic process |
| GO:0014910 | 0.00110 | 2.85878 | 6 | 14 | 84 | regulation of smooth muscle cell migration |
| GO:1903578 | 0.00112 | 2.99624 | 5 | 13 | 75 | regulation of ATP metabolic process |
| GO:0001933 | 0.00116 | 1.72221 | 26 | 43 | 402 | negative regulation of protein phosphorylation |
| GO:0006612 | 0.00122 | 2.60017 | 7 | 16 | 104 | protein targeting to membrane |
| GO:0006259 | 0.00123 | 1.46704 | 59 | 82 | 890 | DNA metabolic process |
| GO:0061448 | 0.00124 | 1.88975 | 18 | 32 | 275 | connective tissue development |
| GO:0070231 | 0.00124 | 3.34232 | 4 | 11 | 58 | T cell apoptotic process |
| GO:0007160 | 0.00131 | 2.07081 | 13 | 25 | 198 | cell-matrix adhesion |
| GO:0046939 | 0.00131 | 2.68064 | 6 | 15 | 95 | nucleotide phosphorylation |
| GO:0060348 | 0.00132 | 2.00552 | 14 | 27 | 220 | bone development |
| GO:1901068 | 0.00133 | 4.38968 | 2 | 8 | 34 | guanosine-containing compound metabolic process |
| GO:1901292 | 0.00135 | 2.34401 | 9 | 19 | 135 | nucleoside phosphate catabolic process |
| GO:0014812 | 0.00136 | 2.57083 | 7 | 16 | 105 | muscle cell migration |
| GO:0001816 | 0.00137 | 1.51875 | 47 | 68 | 714 | cytokine production |
| GO:0042073 | 0.00138 | 3.89215 | 3 | 9 | 42 | intraciliary transport |
| GO:0007229 | 0.00139 | 2.77912 | 6 | 14 | 86 | integrin-mediated signaling pathway |
| GO:0046031 | 0.00139 | 2.77912 | 6 | 14 | 86 | ADP metabolic process |
| GO:0009200 | 0.00139 | 6.10954 | 1 | 6 | 20 | deoxyribonucleoside triphosphate metabolic process |
| GO:0019430 | 0.00139 | 6.10954 | 1 | 6 | 20 | removal of superoxide radicals |
| GO:0042327 | 0.00140 | 1.42572 | 68 | 93 | 1037 | positive regulation of phosphorylation |
| GO:0072332 | 0.00144 | 2.90234 | 5 | 13 | 77 | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0042592 | 0.00146 | 1.31681 | 122 | 154 | 1857 | homeostatic process |
| GO:0090151 | 0.00148 | 7.91639 | 1 | 5 | 14 | establishment of protein localization to mitochondrial membrane |
| GO:2001044 | 0.00148 | 7.91639 | 1 | 5 | 14 | regulation of integrin-mediated signaling pathway |
| GO:0071560 | 0.00151 | 2.04695 | 13 | 25 | 200 | cellular response to transforming growth factor beta stimulus |
| GO:0051604 | 0.00152 | 1.84267 | 19 | 33 | 290 | protein maturation |
| GO:0045596 | 0.00153 | 1.48836 | 51 | 73 | 781 | negative regulation of cell differentiation |
| GO:0045597 | 0.00155 | 1.41211 | 71 | 96 | 1080 | positive regulation of cell differentiation |
| GO:0032680 | 0.00156 | 2.25402 | 10 | 20 | 147 | regulation of tumor necrosis factor production |
| GO:0031325 | 0.00159 | 1.24709 | 206 | 245 | 3128 | positive regulation of cellular metabolic process |
| GO:0014911 | 0.00166 | 3.20560 | 4 | 11 | 60 | positive regulation of smooth muscle cell migration |
| GO:0045669 | 0.00167 | 3.00708 | 5 | 12 | 69 | positive regulation of osteoblast differentiation |
| GO:1901565 | 0.00172 | 1.40171 | 73 | 98 | 1110 | organonitrogen compound catabolic process |
| GO:0016070 | 0.00176 | 1.22779 | 242 | 284 | 3688 | RNA metabolic process |
| GO:0045785 | 0.00179 | 1.69060 | 26 | 42 | 399 | positive regulation of cell adhesion |
| GO:0009162 | 0.00179 | 11.39423 | 1 | 4 | 9 | deoxyribonucleoside monophosphate metabolic process |
| GO:2001046 | 0.00179 | 11.39423 | 1 | 4 | 9 | positive regulation of integrin-mediated signaling pathway |
| GO:1902042 | 0.00182 | 4.75345 | 2 | 7 | 28 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:1901570 | 0.00183 | 3.39874 | 3 | 10 | 52 | fatty acid derivative biosynthetic process |
| GO:0032331 | 0.00184 | 5.70197 | 1 | 6 | 21 | negative regulation of chondrocyte differentiation |
| GO:0032640 | 0.00184 | 2.21886 | 10 | 20 | 149 | tumor necrosis factor production |
| GO:1903555 | 0.00184 | 2.21886 | 10 | 20 | 149 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0045927 | 0.00185 | 1.80046 | 20 | 34 | 305 | positive regulation of growth |
| GO:0001649 | 0.00185 | 2.04626 | 13 | 24 | 192 | osteoblast differentiation |
| GO:0030308 | 0.00185 | 2.04626 | 13 | 24 | 192 | negative regulation of cell growth |
| GO:0001501 | 0.00191 | 1.59874 | 34 | 51 | 510 | skeletal system development |
| GO:1902106 | 0.00200 | 2.55252 | 7 | 15 | 99 | negative regulation of leukocyte differentiation |
| GO:0070372 | 0.00201 | 1.75770 | 22 | 36 | 330 | regulation of ERK1 and ERK2 cascade |
| GO:0060255 | 0.00203 | 1.19384 | 354 | 401 | 5386 | regulation of macromolecule metabolic process |
| GO:0044270 | 0.00203 | 1.64598 | 29 | 45 | 438 | cellular nitrogen compound catabolic process |
| GO:0072594 | 0.00206 | 1.69983 | 25 | 40 | 378 | establishment of protein localization to organelle |
| GO:0000165 | 0.00207 | 1.46483 | 53 | 74 | 803 | MAPK cascade |
| GO:0032102 | 0.00209 | 1.76869 | 21 | 35 | 319 | negative regulation of response to external stimulus |
| GO:0000291 | 0.00210 | 7.12443 | 1 | 5 | 15 | nuclear-transcribed mRNA catabolic process, exonucleolytic |
| GO:0009151 | 0.00210 | 7.12443 | 1 | 5 | 15 | purine deoxyribonucleotide metabolic process |
| GO:0051131 | 0.00210 | 7.12443 | 1 | 5 | 15 | chaperone-mediated protein complex assembly |
| GO:0071559 | 0.00213 | 1.98963 | 13 | 25 | 205 | response to transforming growth factor beta |
| GO:0051129 | 0.00215 | 1.48787 | 48 | 68 | 727 | negative regulation of cellular component organization |
| GO:0070167 | 0.00217 | 2.63236 | 6 | 14 | 90 | regulation of biomineral tissue development |
| GO:0006801 | 0.00218 | 3.07961 | 4 | 11 | 62 | superoxide metabolic process |
| GO:0035556 | 0.00224 | 1.25919 | 169 | 204 | 2571 | intracellular signal transduction |
| GO:0051216 | 0.00227 | 1.97855 | 14 | 25 | 206 | cartilage development |
| GO:0051049 | 0.00230 | 1.29815 | 124 | 155 | 1892 | regulation of transport |
| GO:0071706 | 0.00234 | 2.16813 | 10 | 20 | 152 | tumor necrosis factor superfamily cytokine production |
| GO:1902229 | 0.00238 | 3.93503 | 2 | 8 | 37 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0032462 | 0.00239 | 5.34535 | 1 | 6 | 22 | regulation of protein homooligomerization |
| GO:0034505 | 0.00239 | 5.34535 | 1 | 6 | 22 | tooth mineralization |
| GO:0071450 | 0.00239 | 5.34535 | 1 | 6 | 22 | cellular response to oxygen radical |
| GO:0071451 | 0.00239 | 5.34535 | 1 | 6 | 22 | cellular response to superoxide |
| GO:0014909 | 0.00241 | 2.59805 | 6 | 14 | 91 | smooth muscle cell migration |
| GO:0023014 | 0.00244 | 1.45061 | 54 | 75 | 821 | signal transduction by protein phosphorylation |
| GO:0001952 | 0.00244 | 2.40780 | 7 | 16 | 111 | regulation of cell-matrix adhesion |
| GO:0008217 | 0.00244 | 1.99830 | 13 | 24 | 196 | regulation of blood pressure |
| GO:0017015 | 0.00245 | 2.49293 | 7 | 15 | 101 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032964 | 0.00246 | 3.24395 | 4 | 10 | 54 | collagen biosynthetic process |
| GO:0042743 | 0.00246 | 3.24395 | 4 | 10 | 54 | hydrogen peroxide metabolic process |
| GO:1902105 | 0.00246 | 1.79981 | 19 | 32 | 287 | regulation of leukocyte differentiation |
| GO:1901264 | 0.00248 | 3.02024 | 4 | 11 | 63 | carbohydrate derivative transport |
| GO:0048534 | 0.00249 | 1.41617 | 63 | 85 | 952 | hematopoietic or lymphoid organ development |
| GO:0065008 | 0.00252 | 1.21227 | 260 | 301 | 3955 | regulation of biological quality |
| GO:2001056 | 0.00255 | 2.25831 | 9 | 18 | 132 | positive regulation of cysteine-type endopeptidase activity |
| GO:0001957 | 0.00257 | 21.35311 | 0 | 3 | 5 | intramembranous ossification |
| GO:0009188 | 0.00257 | 21.35311 | 0 | 3 | 5 | ribonucleoside diphosphate biosynthetic process |
| GO:0036072 | 0.00257 | 21.35311 | 0 | 3 | 5 | direct ossification |
| GO:0060620 | 0.00257 | 21.35311 | 0 | 3 | 5 | regulation of cholesterol import |
| GO:0061056 | 0.00257 | 21.35311 | 0 | 3 | 5 | sclerotome development |
| GO:2000909 | 0.00257 | 21.35311 | 0 | 3 | 5 | regulation of sterol import |
| GO:0030097 | 0.00259 | 1.42614 | 59 | 81 | 901 | hemopoiesis |
| GO:0090287 | 0.00262 | 1.83018 | 17 | 30 | 265 | regulation of cellular response to growth factor stimulus |
| GO:0046700 | 0.00264 | 1.62077 | 29 | 45 | 444 | heterocycle catabolic process |
| GO:0080134 | 0.00271 | 1.35875 | 82 | 107 | 1247 | regulation of response to stress |
| GO:1903707 | 0.00273 | 2.13558 | 10 | 20 | 154 | negative regulation of hemopoiesis |
| GO:0070371 | 0.00273 | 1.70757 | 23 | 37 | 348 | ERK1 and ERK2 cascade |
| GO:0019722 | 0.00277 | 1.94602 | 14 | 25 | 209 | calcium-mediated signaling |
| GO:0042744 | 0.00279 | 4.33971 | 2 | 7 | 30 | hydrogen peroxide catabolic process |
| GO:0002679 | 0.00284 | 9.49475 | 1 | 4 | 10 | respiratory burst involved in defense response |
| GO:0006012 | 0.00284 | 9.49475 | 1 | 4 | 10 | galactose metabolic process |
| GO:0006183 | 0.00284 | 9.49475 | 1 | 4 | 10 | GTP biosynthetic process |
| GO:0034427 | 0.00284 | 9.49475 | 1 | 4 | 10 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' |
| GO:0072321 | 0.00284 | 9.49475 | 1 | 4 | 10 | chaperone-mediated protein transport |
| GO:0010631 | 0.00284 | 1.79951 | 18 | 31 | 278 | epithelial cell migration |
| GO:0019439 | 0.00284 | 1.60462 | 30 | 46 | 458 | aromatic compound catabolic process |
| GO:0033628 | 0.00284 | 3.80368 | 2 | 8 | 38 | regulation of cell adhesion mediated by integrin |
| GO:0043403 | 0.00284 | 3.80368 | 2 | 8 | 38 | skeletal muscle tissue regeneration |
| GO:0043085 | 0.00286 | 1.39157 | 68 | 91 | 1036 | positive regulation of catalytic activity |
| GO:0009166 | 0.00287 | 2.29315 | 8 | 17 | 123 | nucleotide catabolic process |
| GO:0032642 | 0.00289 | 2.65283 | 5 | 13 | 83 | regulation of chemokine production |
| GO:0009147 | 0.00289 | 6.47645 | 1 | 5 | 16 | pyrimidine nucleoside triphosphate metabolic process |
| GO:0042772 | 0.00289 | 6.47645 | 1 | 5 | 16 | DNA damage response, signal transduction resulting in transcription |
| GO:0055085 | 0.00292 | 1.35499 | 82 | 107 | 1250 | transmembrane transport |
| GO:0030163 | 0.00293 | 1.42832 | 57 | 78 | 866 | protein catabolic process |
| GO:0006165 | 0.00296 | 2.53205 | 6 | 14 | 93 | nucleoside diphosphate phosphorylation |
| GO:1903844 | 0.00297 | 2.43605 | 7 | 15 | 103 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0090132 | 0.00317 | 1.78489 | 18 | 31 | 280 | epithelium migration |
| GO:0008284 | 0.00320 | 1.39850 | 64 | 86 | 974 | positive regulation of cell proliferation |
| GO:0065009 | 0.00321 | 1.25416 | 160 | 193 | 2437 | regulation of molecular function |
| GO:0009116 | 0.00321 | 2.61535 | 6 | 13 | 84 | nucleoside metabolic process |
| GO:2000241 | 0.00321 | 2.05827 | 11 | 21 | 167 | regulation of reproductive process |
| GO:0048522 | 0.00323 | 1.18359 | 352 | 396 | 5349 | positive regulation of cellular process |
| GO:0031401 | 0.00336 | 1.35564 | 79 | 103 | 1202 | positive regulation of protein modification process |
| GO:0032967 | 0.00340 | 4.15869 | 2 | 7 | 31 | positive regulation of collagen biosynthetic process |
| GO:0006919 | 0.00344 | 2.71994 | 5 | 12 | 75 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0030500 | 0.00344 | 2.71994 | 5 | 12 | 75 | regulation of bone mineralization |
| GO:0098662 | 0.00350 | 1.50773 | 40 | 57 | 601 | inorganic cation transmembrane transport |
| GO:1901136 | 0.00351 | 2.31008 | 8 | 16 | 115 | carbohydrate derivative catabolic process |
| GO:0010563 | 0.00351 | 1.53861 | 35 | 52 | 538 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00351 | 1.53861 | 35 | 52 | 538 | negative regulation of phosphate metabolic process |
| GO:0090130 | 0.00352 | 1.77050 | 19 | 31 | 282 | tissue migration |
| GO:0045185 | 0.00358 | 2.38169 | 7 | 15 | 105 | maintenance of protein location |
| GO:0048661 | 0.00358 | 2.38169 | 7 | 15 | 105 | positive regulation of smooth muscle cell proliferation |
| GO:0061035 | 0.00362 | 2.85511 | 4 | 11 | 66 | regulation of cartilage development |
| GO:0051603 | 0.00365 | 1.47791 | 44 | 62 | 666 | proteolysis involved in cellular protein catabolic process |
| GO:0032330 | 0.00365 | 3.29245 | 3 | 9 | 48 | regulation of chondrocyte differentiation |
| GO:0044093 | 0.00367 | 1.32480 | 93 | 118 | 1408 | positive regulation of molecular function |
| GO:0050729 | 0.00369 | 2.22973 | 8 | 17 | 126 | positive regulation of inflammatory response |
| GO:0002520 | 0.00382 | 1.38261 | 66 | 88 | 1007 | immune system development |
| GO:0001516 | 0.00385 | 4.75099 | 2 | 6 | 24 | prostaglandin biosynthetic process |
| GO:0032461 | 0.00385 | 4.75099 | 2 | 6 | 24 | positive regulation of protein oligomerization |
| GO:0046457 | 0.00385 | 4.75099 | 2 | 6 | 24 | prostanoid biosynthetic process |
| GO:0070584 | 0.00385 | 4.75099 | 2 | 6 | 24 | mitochondrion morphogenesis |
| GO:1901798 | 0.00385 | 4.75099 | 2 | 6 | 24 | positive regulation of signal transduction by p53 class mediator |
| GO:0006656 | 0.00388 | 5.93647 | 1 | 5 | 17 | phosphatidylcholine biosynthetic process |
| GO:0033617 | 0.00388 | 5.93647 | 1 | 5 | 17 | mitochondrial respiratory chain complex IV assembly |
| GO:0045579 | 0.00388 | 5.93647 | 1 | 5 | 17 | positive regulation of B cell differentiation |
| GO:0061081 | 0.00388 | 5.93647 | 1 | 5 | 17 | positive regulation of myeloid leukocyte cytokine production involved in immune response |
| GO:0070374 | 0.00392 | 1.81514 | 16 | 28 | 249 | positive regulation of ERK1 and ERK2 cascade |
| GO:0030278 | 0.00393 | 1.86180 | 15 | 26 | 226 | regulation of ossification |
| GO:0043408 | 0.00398 | 1.44487 | 49 | 68 | 746 | regulation of MAPK cascade |
| GO:0031400 | 0.00399 | 1.52120 | 36 | 53 | 554 | negative regulation of protein modification process |
| GO:0050790 | 0.00405 | 1.28567 | 117 | 145 | 1782 | regulation of catalytic activity |
| GO:0061061 | 0.00405 | 1.46531 | 45 | 63 | 682 | muscle structure development |
| GO:0007031 | 0.00411 | 3.99216 | 2 | 7 | 32 | peroxisome organization |
| GO:0045047 | 0.00411 | 3.99216 | 2 | 7 | 32 | protein targeting to ER |
| GO:0002062 | 0.00417 | 2.26413 | 8 | 16 | 117 | chondrocyte differentiation |
| GO:0046434 | 0.00418 | 1.93646 | 13 | 23 | 193 | organophosphate catabolic process |
| GO:0062012 | 0.00420 | 1.68449 | 22 | 35 | 333 | regulation of small molecule metabolic process |
| GO:1902041 | 0.00422 | 3.20999 | 3 | 9 | 49 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0006616 | 0.00423 | 8.13798 | 1 | 4 | 11 | SRP-dependent cotranslational protein targeting to membrane, translocation |
| GO:0032464 | 0.00423 | 8.13798 | 1 | 4 | 11 | positive regulation of protein homooligomerization |
| GO:0032490 | 0.00423 | 8.13798 | 1 | 4 | 11 | detection of molecule of bacterial origin |
| GO:0046386 | 0.00423 | 8.13798 | 1 | 4 | 11 | deoxyribose phosphate catabolic process |
| GO:0006575 | 0.00425 | 2.04348 | 11 | 20 | 160 | cellular modified amino acid metabolic process |
| GO:0072657 | 0.00426 | 1.53556 | 34 | 50 | 518 | protein localization to membrane |
| GO:0002260 | 0.00429 | 2.63601 | 5 | 12 | 77 | lymphocyte homeostasis |
| GO:0070228 | 0.00429 | 2.63601 | 5 | 12 | 77 | regulation of lymphocyte apoptotic process |
| GO:0043467 | 0.00430 | 2.32970 | 7 | 15 | 107 | regulation of generation of precursor metabolites and energy |
| GO:0005985 | 0.00432 | Inf | 0 | 2 | 2 | sucrose metabolic process |
| GO:0005986 | 0.00432 | Inf | 0 | 2 | 2 | sucrose biosynthetic process |
| GO:0042262 | 0.00432 | Inf | 0 | 2 | 2 | DNA protection |
| GO:0046710 | 0.00432 | Inf | 0 | 2 | 2 | GDP metabolic process |
| GO:0060265 | 0.00432 | Inf | 0 | 2 | 2 | positive regulation of respiratory burst involved in inflammatory response |
| GO:0060854 | 0.00432 | Inf | 0 | 2 | 2 | branching involved in lymph vessel morphogenesis |
| GO:0097238 | 0.00432 | Inf | 0 | 2 | 2 | cellular response to methylglyoxal |
| GO:0099551 | 0.00432 | Inf | 0 | 2 | 2 | trans-synaptic signaling by neuropeptide, modulating synaptic transmission |
| GO:1902164 | 0.00432 | Inf | 0 | 2 | 2 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:1905938 | 0.00432 | Inf | 0 | 2 | 2 | positive regulation of germ cell proliferation |
| GO:2000256 | 0.00432 | Inf | 0 | 2 | 2 | positive regulation of male germ cell proliferation |
| GO:0032602 | 0.00438 | 2.50897 | 6 | 13 | 87 | chemokine production |
| GO:0051235 | 0.00440 | 1.70803 | 20 | 33 | 310 | maintenance of location |
| GO:0044257 | 0.00449 | 1.44877 | 47 | 65 | 711 | cellular protein catabolic process |
| GO:0006812 | 0.00452 | 1.36078 | 71 | 93 | 1080 | cation transport |
| GO:0098660 | 0.00455 | 1.47083 | 43 | 60 | 647 | inorganic ion transmembrane transport |
| GO:0044782 | 0.00462 | 1.68690 | 21 | 34 | 323 | cilium organization |
| GO:0032459 | 0.00467 | 3.45742 | 3 | 8 | 41 | regulation of protein oligomerization |
| GO:0032722 | 0.00479 | 2.91226 | 4 | 10 | 59 | positive regulation of chemokine production |
| GO:0000303 | 0.00479 | 4.50073 | 2 | 6 | 25 | response to superoxide |
| GO:0006221 | 0.00479 | 4.50073 | 2 | 6 | 25 | pyrimidine nucleotide biosynthetic process |
| GO:0032269 | 0.00480 | 1.37428 | 65 | 86 | 989 | negative regulation of cellular protein metabolic process |
| GO:0031333 | 0.00482 | 2.10945 | 9 | 18 | 140 | negative regulation of protein complex assembly |
| GO:0002536 | 0.00488 | 14.23475 | 0 | 3 | 6 | respiratory burst involved in inflammatory response |
| GO:0002826 | 0.00488 | 14.23475 | 0 | 3 | 6 | negative regulation of T-helper 1 type immune response |
| GO:0009186 | 0.00488 | 14.23475 | 0 | 3 | 6 | deoxyribonucleoside diphosphate metabolic process |
| GO:0035633 | 0.00488 | 14.23475 | 0 | 3 | 6 | maintenance of permeability of blood-brain barrier |
| GO:0046826 | 0.00488 | 14.23475 | 0 | 3 | 6 | negative regulation of protein export from nucleus |
| GO:0051541 | 0.00488 | 14.23475 | 0 | 3 | 6 | elastin metabolic process |
| GO:0060708 | 0.00488 | 14.23475 | 0 | 3 | 6 | spongiotrophoblast differentiation |
| GO:0009889 | 0.00492 | 1.20576 | 227 | 263 | 3456 | regulation of biosynthetic process |
| GO:0006310 | 0.00496 | 1.76043 | 17 | 29 | 265 | DNA recombination |
| GO:0030150 | 0.00508 | 5.47957 | 1 | 5 | 18 | protein import into mitochondrial matrix |
| GO:0051444 | 0.00508 | 5.47957 | 1 | 5 | 18 | negative regulation of ubiquitin-protein transferase activity |
| GO:0019318 | 0.00510 | 1.84485 | 14 | 25 | 219 | hexose metabolic process |
| GO:2000106 | 0.00512 | 2.27992 | 7 | 15 | 109 | regulation of leukocyte apoptotic process |
| GO:2000107 | 0.00513 | 2.70706 | 5 | 11 | 69 | negative regulation of leukocyte apoptotic process |
| GO:0048518 | 0.00519 | 1.16544 | 397 | 440 | 6033 | positive regulation of biological process |
| GO:0030155 | 0.00521 | 1.45556 | 44 | 61 | 664 | regulation of cell adhesion |
| GO:0050673 | 0.00544 | 1.58596 | 27 | 41 | 412 | epithelial cell proliferation |
| GO:0043632 | 0.00554 | 1.48709 | 38 | 54 | 576 | modification-dependent macromolecule catabolic process |
| GO:0030219 | 0.00555 | 3.05685 | 3 | 9 | 51 | megakaryocyte differentiation |
| GO:0071363 | 0.00577 | 1.47792 | 39 | 55 | 590 | cellular response to growth factor stimulus |
| GO:0051051 | 0.00585 | 1.51374 | 34 | 49 | 514 | negative regulation of transport |
| GO:0002675 | 0.00586 | 3.69611 | 2 | 7 | 34 | positive regulation of acute inflammatory response |
| GO:0010714 | 0.00586 | 3.69611 | 2 | 7 | 34 | positive regulation of collagen metabolic process |
| GO:0043516 | 0.00586 | 3.69611 | 2 | 7 | 34 | regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0043154 | 0.00587 | 2.51936 | 5 | 12 | 80 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0000305 | 0.00589 | 4.27549 | 2 | 6 | 26 | response to oxygen radical |
| GO:0035929 | 0.00589 | 4.27549 | 2 | 6 | 26 | steroid hormone secretion |
| GO:0070233 | 0.00589 | 4.27549 | 2 | 6 | 26 | negative regulation of T cell apoptotic process |
| GO:0006123 | 0.00601 | 7.12041 | 1 | 4 | 12 | mitochondrial electron transport, cytochrome c to oxygen |
| GO:0009264 | 0.00601 | 7.12041 | 1 | 4 | 12 | deoxyribonucleotide catabolic process |
| GO:0009265 | 0.00601 | 7.12041 | 1 | 4 | 12 | 2'-deoxyribonucleotide biosynthetic process |
| GO:0019646 | 0.00601 | 7.12041 | 1 | 4 | 12 | aerobic electron transport chain |
| GO:0046385 | 0.00601 | 7.12041 | 1 | 4 | 12 | deoxyribose phosphate biosynthetic process |
| GO:0097428 | 0.00601 | 7.12041 | 1 | 4 | 12 | protein maturation by iron-sulfur cluster transfer |
| GO:0070838 | 0.00605 | 1.54810 | 30 | 44 | 452 | divalent metal ion transport |
| GO:0030330 | 0.00611 | 2.79780 | 4 | 10 | 61 | DNA damage response, signal transduction by p53 class mediator |
| GO:0033627 | 0.00611 | 2.79780 | 4 | 10 | 61 | cell adhesion mediated by integrin |
| GO:0032970 | 0.00616 | 1.60304 | 25 | 38 | 378 | regulation of actin filament-based process |
| GO:0070925 | 0.00624 | 1.40912 | 51 | 69 | 774 | organelle assembly |
| GO:0090066 | 0.00625 | 1.48845 | 36 | 52 | 554 | regulation of anatomical structure size |
| GO:0042771 | 0.00630 | 3.25955 | 3 | 8 | 43 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0070232 | 0.00630 | 3.25955 | 3 | 8 | 43 | regulation of T cell apoptotic process |
| GO:0001659 | 0.00632 | 1.92544 | 12 | 21 | 177 | temperature homeostasis |
| GO:0010712 | 0.00633 | 2.98562 | 3 | 9 | 52 | regulation of collagen metabolic process |
| GO:0030514 | 0.00633 | 2.98562 | 3 | 9 | 52 | negative regulation of BMP signaling pathway |
| GO:0072527 | 0.00633 | 2.98562 | 3 | 9 | 52 | pyrimidine-containing compound metabolic process |
| GO:0072331 | 0.00640 | 2.09450 | 9 | 17 | 133 | signal transduction by p53 class mediator |
| GO:2001020 | 0.00644 | 1.85927 | 13 | 23 | 200 | regulation of response to DNA damage stimulus |
| GO:0030220 | 0.00653 | 5.08794 | 1 | 5 | 19 | platelet formation |
| GO:0033630 | 0.00653 | 5.08794 | 1 | 5 | 19 | positive regulation of cell adhesion mediated by integrin |
| GO:0090201 | 0.00653 | 5.08794 | 1 | 5 | 19 | negative regulation of release of cytochrome c from mitochondria |
| GO:0002683 | 0.00653 | 1.54040 | 30 | 44 | 454 | negative regulation of immune system process |
| GO:0032368 | 0.00659 | 2.20910 | 7 | 15 | 112 | regulation of lipid transport |
| GO:2001234 | 0.00678 | 1.79808 | 15 | 25 | 224 | negative regulation of apoptotic signaling pathway |
| GO:0072511 | 0.00679 | 1.53658 | 30 | 44 | 455 | divalent inorganic cation transport |
| GO:0060393 | 0.00686 | 2.74387 | 4 | 10 | 62 | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0018208 | 0.00692 | 3.56394 | 2 | 7 | 35 | peptidyl-proline modification |
| GO:0048878 | 0.00706 | 1.32717 | 76 | 97 | 1152 | chemical homeostasis |
| GO:0050732 | 0.00719 | 2.91763 | 3 | 9 | 53 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0002063 | 0.00727 | 3.16886 | 3 | 8 | 44 | chondrocyte development |
| GO:0006888 | 0.00733 | 2.11670 | 8 | 16 | 124 | ER to Golgi vesicle-mediated transport |
| GO:0010811 | 0.00733 | 2.11670 | 8 | 16 | 124 | positive regulation of cell-substrate adhesion |
| GO:0010959 | 0.00734 | 1.56339 | 27 | 40 | 407 | regulation of metal ion transport |
| GO:0051924 | 0.00743 | 1.72070 | 17 | 28 | 261 | regulation of calcium ion transport |
| GO:0006468 | 0.00764 | 1.25923 | 118 | 144 | 1801 | protein phosphorylation |
| GO:0051336 | 0.00764 | 1.35327 | 64 | 83 | 967 | regulation of hydrolase activity |
| GO:2000242 | 0.00769 | 2.69197 | 4 | 10 | 63 | negative regulation of reproductive process |
| GO:0010212 | 0.00791 | 2.09718 | 8 | 16 | 125 | response to ionizing radiation |
| GO:0072599 | 0.00812 | 3.44089 | 2 | 7 | 36 | establishment of protein localization to endoplasmic reticulum |
| GO:0005984 | 0.00812 | 10.67557 | 0 | 3 | 7 | disaccharide metabolic process |
| GO:0009438 | 0.00812 | 10.67557 | 0 | 3 | 7 | methylglyoxal metabolic process |
| GO:0016078 | 0.00812 | 10.67557 | 0 | 3 | 7 | tRNA catabolic process |
| GO:0032493 | 0.00812 | 10.67557 | 0 | 3 | 7 | response to bacterial lipoprotein |
| GO:0060373 | 0.00812 | 10.67557 | 0 | 3 | 7 | regulation of ventricular cardiac muscle cell membrane depolarization |
| GO:1905936 | 0.00812 | 10.67557 | 0 | 3 | 7 | regulation of germ cell proliferation |
| GO:2000254 | 0.00812 | 10.67557 | 0 | 3 | 7 | regulation of male germ cell proliferation |
| GO:0002281 | 0.00824 | 6.32896 | 1 | 4 | 13 | macrophage activation involved in immune response |
| GO:0006122 | 0.00824 | 6.32896 | 1 | 4 | 13 | mitochondrial electron transport, ubiquinol to cytochrome c |
| GO:0009148 | 0.00824 | 6.32896 | 1 | 4 | 13 | pyrimidine nucleoside triphosphate biosynthetic process |
| GO:0010935 | 0.00824 | 6.32896 | 1 | 4 | 13 | regulation of macrophage cytokine production |
| GO:0031652 | 0.00824 | 6.32896 | 1 | 4 | 13 | positive regulation of heat generation |
| GO:0048672 | 0.00824 | 6.32896 | 1 | 4 | 13 | positive regulation of collateral sprouting |
| GO:0071027 | 0.00824 | 6.32896 | 1 | 4 | 13 | nuclear RNA surveillance |
| GO:0071028 | 0.00824 | 6.32896 | 1 | 4 | 13 | nuclear mRNA surveillance |
| GO:0071285 | 0.00824 | 6.32896 | 1 | 4 | 13 | cellular response to lithium ion |
| GO:0090197 | 0.00824 | 6.32896 | 1 | 4 | 13 | positive regulation of chemokine secretion |
| GO:0099116 | 0.00824 | 6.32896 | 1 | 4 | 13 | tRNA 5'-end processing |
| GO:0008535 | 0.00824 | 4.74852 | 1 | 5 | 20 | respiratory chain complex IV assembly |
| GO:0033033 | 0.00824 | 4.74852 | 1 | 5 | 20 | negative regulation of myeloid cell apoptotic process |
| GO:0036344 | 0.00824 | 4.74852 | 1 | 5 | 20 | platelet morphogenesis |
| GO:0032965 | 0.00834 | 3.08307 | 3 | 8 | 45 | regulation of collagen biosynthetic process |
| GO:1903018 | 0.00834 | 3.08307 | 3 | 8 | 45 | regulation of glycoprotein metabolic process |
| GO:0031399 | 0.00846 | 1.25954 | 114 | 139 | 1737 | regulation of protein modification process |
| GO:0008380 | 0.00850 | 1.58774 | 24 | 36 | 361 | RNA splicing |
| GO:0034248 | 0.00850 | 1.58774 | 24 | 36 | 361 | regulation of cellular amide metabolic process |
| GO:0001817 | 0.00857 | 1.42988 | 42 | 58 | 641 | regulation of cytokine production |
| GO:0010810 | 0.00860 | 1.80777 | 13 | 23 | 205 | regulation of cell-substrate adhesion |
| GO:0061082 | 0.00861 | 3.88645 | 2 | 6 | 28 | myeloid leukocyte cytokine production |
| GO:0072528 | 0.00861 | 3.88645 | 2 | 6 | 28 | pyrimidine-containing compound biosynthetic process |
| GO:1901361 | 0.00868 | 1.49706 | 32 | 46 | 487 | organic cyclic compound catabolic process |
| GO:0030029 | 0.00873 | 1.40311 | 47 | 64 | 720 | actin filament-based process |
| GO:0006979 | 0.00875 | 1.55341 | 26 | 39 | 399 | response to oxidative stress |
| GO:0044057 | 0.00878 | 1.45285 | 38 | 53 | 577 | regulation of system process |
| GO:0009914 | 0.00886 | 1.58280 | 24 | 36 | 362 | hormone transport |
| GO:0000302 | 0.00889 | 1.82934 | 13 | 22 | 194 | response to reactive oxygen species |
| GO:0043542 | 0.00889 | 1.82934 | 13 | 22 | 194 | endothelial cell migration |
| GO:0070848 | 0.00911 | 1.43928 | 40 | 55 | 604 | response to growth factor |
| GO:0120031 | 0.00932 | 1.49016 | 32 | 46 | 489 | plasma membrane bounded cell projection assembly |
| GO:0019941 | 0.00934 | 1.45288 | 37 | 52 | 566 | modification-dependent protein catabolic process |
| GO:0051188 | 0.00938 | 1.74497 | 15 | 25 | 230 | cofactor biosynthetic process |
| GO:0030031 | 0.00940 | 1.48256 | 33 | 47 | 502 | cell projection assembly |
| GO:0051345 | 0.00940 | 1.48256 | 33 | 47 | 502 | positive regulation of hydrolase activity |
| GO:0006636 | 0.00945 | 3.32604 | 2 | 7 | 37 | unsaturated fatty acid biosynthetic process |
| GO:0045684 | 0.00945 | 3.32604 | 2 | 7 | 37 | positive regulation of epidermis development |
| GO:2000117 | 0.00950 | 2.34626 | 6 | 12 | 85 | negative regulation of cysteine-type endopeptidase activity |
| GO:0033173 | 0.00953 | 3.00180 | 3 | 8 | 46 | calcineurin-NFAT signaling cascade |
| GO:0060389 | 0.00957 | 2.59384 | 4 | 10 | 65 | pathway-restricted SMAD protein phosphorylation |
| GO:1901657 | 0.00957 | 2.17295 | 7 | 14 | 106 | glycosyl compound metabolic process |
| GO:0007179 | 0.00960 | 1.91252 | 11 | 19 | 161 | transforming growth factor beta receptor signaling pathway |
| GO:0051223 | 0.00962 | 1.40750 | 45 | 61 | 684 | regulation of protein transport |
| GO:0002718 | 0.00964 | 2.45259 | 5 | 11 | 75 | regulation of cytokine production involved in immune response |
| GO:0033135 | 0.00975 | 1.94874 | 10 | 18 | 150 | regulation of peptidyl-serine phosphorylation |
| GO:0090087 | 0.00978 | 1.39434 | 48 | 64 | 724 | regulation of peptide transport |
| GO:1903426 | 0.01003 | 2.23599 | 6 | 13 | 96 | regulation of reactive oxygen species biosynthetic process |
| GO:0048660 | 0.01022 | 1.89906 | 11 | 19 | 162 | regulation of smooth muscle cell proliferation |
| GO:2001236 | 0.01022 | 1.89906 | 11 | 19 | 162 | regulation of extrinsic apoptotic signaling pathway |
| GO:0000469 | 0.01024 | 4.45153 | 1 | 5 | 21 | cleavage involved in rRNA processing |
| GO:0001958 | 0.01027 | 3.71731 | 2 | 6 | 29 | endochondral ossification |
| GO:0034110 | 0.01027 | 3.71731 | 2 | 6 | 29 | regulation of homotypic cell-cell adhesion |
| GO:0036075 | 0.01027 | 3.71731 | 2 | 6 | 29 | replacement ossification |
| GO:0046039 | 0.01027 | 3.71731 | 2 | 6 | 29 | GTP metabolic process |
| GO:0061037 | 0.01027 | 3.71731 | 2 | 6 | 29 | negative regulation of cartilage development |
| GO:0010639 | 0.01044 | 1.54306 | 26 | 38 | 391 | negative regulation of organelle organization |
| GO:0045667 | 0.01054 | 1.97466 | 9 | 17 | 140 | regulation of osteoblast differentiation |
| GO:0002526 | 0.01054 | 2.07984 | 8 | 15 | 118 | acute inflammatory response |
| GO:0010821 | 0.01059 | 2.02257 | 8 | 16 | 129 | regulation of mitochondrion organization |
| GO:0006417 | 0.01062 | 1.60811 | 21 | 32 | 317 | regulation of translation |
| GO:0070201 | 0.01070 | 1.39117 | 47 | 63 | 714 | regulation of establishment of protein localization |
| GO:1905517 | 0.01084 | 2.92470 | 3 | 8 | 47 | macrophage migration |
| GO:1903034 | 0.01088 | 1.88578 | 11 | 19 | 163 | regulation of response to wounding |
| GO:0032963 | 0.01091 | 2.20926 | 6 | 13 | 97 | collagen metabolic process |
| GO:0045638 | 0.01091 | 2.20926 | 6 | 13 | 97 | negative regulation of myeloid cell differentiation |
| GO:0070227 | 0.01091 | 2.20926 | 6 | 13 | 97 | lymphocyte apoptotic process |
| GO:0006662 | 0.01094 | 5.69580 | 1 | 4 | 14 | glycerol ether metabolic process |
| GO:0009215 | 0.01094 | 5.69580 | 1 | 4 | 14 | purine deoxyribonucleoside triphosphate metabolic process |
| GO:0010226 | 0.01094 | 5.69580 | 1 | 4 | 14 | response to lithium ion |
| GO:0034471 | 0.01094 | 5.69580 | 1 | 4 | 14 | ncRNA 5'-end processing |
| GO:0043248 | 0.01094 | 5.69580 | 1 | 4 | 14 | proteasome assembly |
| GO:0070486 | 0.01094 | 5.69580 | 1 | 4 | 14 | leukocyte aggregation |
| GO:0090196 | 0.01094 | 5.69580 | 1 | 4 | 14 | regulation of chemokine secretion |
| GO:0006816 | 0.01103 | 1.52751 | 27 | 39 | 405 | calcium ion transport |
| GO:0003012 | 0.01107 | 1.54594 | 25 | 37 | 380 | muscle system process |
| GO:0031326 | 0.01118 | 1.18267 | 223 | 254 | 3386 | regulation of cellular biosynthetic process |
| GO:0001776 | 0.01121 | 2.12652 | 7 | 14 | 108 | leukocyte homeostasis |
| GO:0001935 | 0.01128 | 1.95864 | 9 | 17 | 141 | endothelial cell proliferation |
| GO:0051289 | 0.01136 | 2.28348 | 6 | 12 | 87 | protein homotetramerization |
| GO:0001837 | 0.01137 | 2.00473 | 9 | 16 | 130 | epithelial to mesenchymal transition |
| GO:0061041 | 0.01137 | 2.00473 | 9 | 16 | 130 | regulation of wound healing |
| GO:0010948 | 0.01144 | 1.73380 | 15 | 24 | 222 | negative regulation of cell cycle process |
| GO:0048771 | 0.01155 | 1.80861 | 12 | 21 | 187 | tissue remodeling |
| GO:0043410 | 0.01161 | 1.44995 | 35 | 49 | 534 | positive regulation of MAPK cascade |
| GO:0007517 | 0.01162 | 1.51304 | 28 | 40 | 419 | muscle organ development |
| GO:0007166 | 0.01162 | 1.20842 | 163 | 190 | 2473 | cell surface receptor signaling pathway |
| GO:0032370 | 0.01178 | 2.50260 | 4 | 10 | 67 | positive regulation of lipid transport |
| GO:0045778 | 0.01184 | 2.18317 | 6 | 13 | 98 | positive regulation of ossification |
| GO:0022610 | 0.01196 | 1.28384 | 84 | 105 | 1285 | biological adhesion |
| GO:1902904 | 0.01205 | 1.94288 | 9 | 17 | 142 | negative regulation of supramolecular fiber organization |
| GO:1905952 | 0.01205 | 1.94288 | 9 | 17 | 142 | regulation of lipid localization |
| GO:0045652 | 0.01214 | 3.56225 | 2 | 6 | 30 | regulation of megakaryocyte differentiation |
| GO:0061036 | 0.01214 | 3.56225 | 2 | 6 | 30 | positive regulation of cartilage development |
| GO:1902253 | 0.01214 | 3.56225 | 2 | 6 | 30 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0032535 | 0.01216 | 1.52549 | 26 | 38 | 395 | regulation of cellular component size |
| GO:0071887 | 0.01218 | 1.98721 | 9 | 16 | 131 | leukocyte apoptotic process |
| GO:0017001 | 0.01228 | 2.85145 | 3 | 8 | 48 | antibiotic catabolic process |
| GO:0051262 | 0.01230 | 1.85978 | 11 | 19 | 165 | protein tetramerization |
| GO:0006228 | 0.01237 | 8.54007 | 1 | 3 | 8 | UTP biosynthetic process |
| GO:0032511 | 0.01237 | 8.54007 | 1 | 3 | 8 | late endosome to vacuole transport via multivesicular body sorting pathway |
| GO:0046060 | 0.01237 | 8.54007 | 1 | 3 | 8 | dATP metabolic process |
| GO:0060371 | 0.01237 | 8.54007 | 1 | 3 | 8 | regulation of atrial cardiac muscle cell membrane depolarization |
| GO:0060907 | 0.01237 | 8.54007 | 1 | 3 | 8 | positive regulation of macrophage cytokine production |
| GO:0071493 | 0.01237 | 8.54007 | 1 | 3 | 8 | cellular response to UV-B |
| GO:1902255 | 0.01237 | 8.54007 | 1 | 3 | 8 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:2000542 | 0.01237 | 8.54007 | 1 | 3 | 8 | negative regulation of gastrulation |
| GO:0007155 | 0.01239 | 1.28337 | 84 | 104 | 1273 | cell adhesion |
| GO:0002540 | 0.01239 | 28.45347 | 0 | 2 | 3 | leukotriene production involved in inflammatory response |
| GO:0006172 | 0.01239 | 28.45347 | 0 | 2 | 3 | ADP biosynthetic process |
| GO:0009182 | 0.01239 | 28.45347 | 0 | 2 | 3 | purine deoxyribonucleoside diphosphate metabolic process |
| GO:0031120 | 0.01239 | 28.45347 | 0 | 2 | 3 | snRNA pseudouridine synthesis |
| GO:0031204 | 0.01239 | 28.45347 | 0 | 2 | 3 | posttranslational protein targeting to membrane, translocation |
| GO:0034436 | 0.01239 | 28.45347 | 0 | 2 | 3 | glycoprotein transport |
| GO:0034473 | 0.01239 | 28.45347 | 0 | 2 | 3 | U1 snRNA 3'-end processing |
| GO:0034476 | 0.01239 | 28.45347 | 0 | 2 | 3 | U5 snRNA 3'-end processing |
| GO:0044691 | 0.01239 | 28.45347 | 0 | 2 | 3 | tooth eruption |
| GO:0045626 | 0.01239 | 28.45347 | 0 | 2 | 3 | negative regulation of T-helper 1 cell differentiation |
| GO:0046066 | 0.01239 | 28.45347 | 0 | 2 | 3 | dGDP metabolic process |
| GO:0051595 | 0.01239 | 28.45347 | 0 | 2 | 3 | response to methylglyoxal |
| GO:0060309 | 0.01239 | 28.45347 | 0 | 2 | 3 | elastin catabolic process |
| GO:0061146 | 0.01239 | 28.45347 | 0 | 2 | 3 | Peyer's patch morphogenesis |
| GO:0061182 | 0.01239 | 28.45347 | 0 | 2 | 3 | negative regulation of chondrocyte development |
| GO:0061623 | 0.01239 | 28.45347 | 0 | 2 | 3 | glycolytic process from galactose |
| GO:0071725 | 0.01239 | 28.45347 | 0 | 2 | 3 | response to triacyl bacterial lipopeptide |
| GO:0071727 | 0.01239 | 28.45347 | 0 | 2 | 3 | cellular response to triacyl bacterial lipopeptide |
| GO:0072061 | 0.01239 | 28.45347 | 0 | 2 | 3 | inner medullary collecting duct development |
| GO:0086047 | 0.01239 | 28.45347 | 0 | 2 | 3 | membrane depolarization during Purkinje myocyte cell action potential |
| GO:0098883 | 0.01239 | 28.45347 | 0 | 2 | 3 | synapse pruning |
| GO:0099540 | 0.01239 | 28.45347 | 0 | 2 | 3 | trans-synaptic signaling by neuropeptide |
| GO:0110095 | 0.01239 | 28.45347 | 0 | 2 | 3 | cellular detoxification of aldehyde |
| GO:1901656 | 0.01239 | 28.45347 | 0 | 2 | 3 | glycoside transport |
| GO:1902162 | 0.01239 | 28.45347 | 0 | 2 | 3 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:1902445 | 0.01239 | 28.45347 | 0 | 2 | 3 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death |
| GO:1902606 | 0.01239 | 28.45347 | 0 | 2 | 3 | regulation of large conductance calcium-activated potassium channel activity |
| GO:1902608 | 0.01239 | 28.45347 | 0 | 2 | 3 | positive regulation of large conductance calcium-activated potassium channel activity |
| GO:1902956 | 0.01239 | 28.45347 | 0 | 2 | 3 | regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:1904578 | 0.01239 | 28.45347 | 0 | 2 | 3 | response to thapsigargin |
| GO:1904579 | 0.01239 | 28.45347 | 0 | 2 | 3 | cellular response to thapsigargin |
| GO:1905907 | 0.01239 | 28.45347 | 0 | 2 | 3 | negative regulation of amyloid fibril formation |
| GO:0043567 | 0.01255 | 4.18949 | 1 | 5 | 22 | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0000027 | 0.01260 | 3.11787 | 3 | 7 | 39 | ribosomal large subunit assembly |
| GO:0050848 | 0.01284 | 2.15769 | 7 | 13 | 99 | regulation of calcium-mediated signaling |
| GO:0060271 | 0.01294 | 1.60844 | 20 | 30 | 297 | cilium assembly |
| GO:0051260 | 0.01296 | 1.54744 | 24 | 35 | 359 | protein homooligomerization |
| GO:0006081 | 0.01302 | 2.45934 | 4 | 10 | 68 | cellular aldehyde metabolic process |
| GO:0048762 | 0.01326 | 1.73101 | 14 | 23 | 213 | mesenchymal cell differentiation |
| GO:0017038 | 0.01334 | 1.70768 | 15 | 24 | 225 | protein import |
| GO:0005996 | 0.01334 | 1.66799 | 16 | 26 | 249 | monosaccharide metabolic process |
| GO:0010332 | 0.01385 | 2.78177 | 3 | 8 | 49 | response to gamma radiation |
| GO:0031663 | 0.01385 | 2.78177 | 3 | 8 | 49 | lipopolysaccharide-mediated signaling pathway |
| GO:0070229 | 0.01385 | 2.78177 | 3 | 8 | 49 | negative regulation of lymphocyte apoptotic process |
| GO:0097720 | 0.01385 | 2.78177 | 3 | 8 | 49 | calcineurin-mediated signaling |
| GO:0048659 | 0.01386 | 1.83448 | 11 | 19 | 167 | smooth muscle cell proliferation |
| GO:0003013 | 0.01386 | 1.46391 | 31 | 44 | 475 | circulatory system process |
| GO:0008033 | 0.01407 | 2.06047 | 7 | 14 | 111 | tRNA processing |
| GO:0046165 | 0.01408 | 2.00172 | 8 | 15 | 122 | alcohol biosynthetic process |
| GO:0003188 | 0.01415 | 5.17776 | 1 | 4 | 15 | heart valve formation |
| GO:0006978 | 0.01415 | 5.17776 | 1 | 4 | 15 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0009263 | 0.01415 | 5.17776 | 1 | 4 | 15 | deoxyribonucleotide biosynthetic process |
| GO:0010934 | 0.01415 | 5.17776 | 1 | 4 | 15 | macrophage cytokine production |
| GO:0031650 | 0.01415 | 5.17776 | 1 | 4 | 15 | regulation of heat generation |
| GO:0042095 | 0.01415 | 5.17776 | 1 | 4 | 15 | interferon-gamma biosynthetic process |
| GO:0060055 | 0.01415 | 5.17776 | 1 | 4 | 15 | angiogenesis involved in wound healing |
| GO:0060442 | 0.01415 | 5.17776 | 1 | 4 | 15 | branching involved in prostate gland morphogenesis |
| GO:0061051 | 0.01415 | 5.17776 | 1 | 4 | 15 | positive regulation of cell growth involved in cardiac muscle cell development |
| GO:0061430 | 0.01415 | 5.17776 | 1 | 4 | 15 | bone trabecula morphogenesis |
| GO:0070166 | 0.01415 | 5.17776 | 1 | 4 | 15 | enamel mineralization |
| GO:0071025 | 0.01415 | 5.17776 | 1 | 4 | 15 | RNA surveillance |
| GO:0090195 | 0.01415 | 5.17776 | 1 | 4 | 15 | chemokine secretion |
| GO:1902165 | 0.01415 | 5.17776 | 1 | 4 | 15 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0000387 | 0.01423 | 3.41961 | 2 | 6 | 31 | spliceosomal snRNP assembly |
| GO:0000462 | 0.01423 | 3.41961 | 2 | 6 | 31 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:2000515 | 0.01423 | 3.41961 | 2 | 6 | 31 | negative regulation of CD4-positive, alpha-beta T cell activation |
| GO:1901796 | 0.01435 | 2.41754 | 5 | 10 | 69 | regulation of signal transduction by p53 class mediator |
| GO:0030837 | 0.01435 | 2.56681 | 4 | 9 | 59 | negative regulation of actin filament polymerization |
| GO:0051187 | 0.01435 | 2.56681 | 4 | 9 | 59 | cofactor catabolic process |
| GO:0001819 | 0.01443 | 1.48904 | 28 | 40 | 425 | positive regulation of cytokine production |
| GO:0010559 | 0.01443 | 3.02325 | 3 | 7 | 40 | regulation of glycoprotein biosynthetic process |
| GO:0034105 | 0.01443 | 3.02325 | 3 | 7 | 40 | positive regulation of tissue remodeling |
| GO:0051050 | 0.01483 | 1.30220 | 69 | 87 | 1049 | positive regulation of transport |
| GO:0007178 | 0.01487 | 1.54083 | 23 | 34 | 350 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0051897 | 0.01502 | 2.10845 | 7 | 13 | 101 | positive regulation of protein kinase B signaling |
| GO:1903409 | 0.01514 | 2.03935 | 7 | 14 | 112 | reactive oxygen species biosynthetic process |
| GO:0043371 | 0.01518 | 3.95656 | 2 | 5 | 23 | negative regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0070168 | 0.01518 | 3.95656 | 2 | 5 | 23 | negative regulation of biomineral tissue development |
| GO:0008285 | 0.01530 | 1.37770 | 44 | 59 | 674 | negative regulation of cell proliferation |
| GO:0010035 | 0.01532 | 1.45358 | 31 | 44 | 478 | response to inorganic substance |
| GO:0009306 | 0.01539 | 1.41271 | 37 | 51 | 569 | protein secretion |
| GO:0007169 | 0.01543 | 1.42844 | 35 | 48 | 530 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0016485 | 0.01548 | 1.68234 | 15 | 24 | 228 | protein processing |
| GO:0008015 | 0.01577 | 1.45726 | 31 | 43 | 466 | blood circulation |
| GO:0002532 | 0.01579 | 2.37714 | 5 | 10 | 70 | production of molecular mediator involved in inflammatory response |
| GO:0043491 | 0.01587 | 1.77521 | 12 | 20 | 181 | protein kinase B signaling |
| GO:0006261 | 0.01591 | 1.92006 | 9 | 16 | 135 | DNA-dependent DNA replication |
| GO:0048246 | 0.01644 | 2.93420 | 3 | 7 | 41 | macrophage chemotaxis |
| GO:0045577 | 0.01656 | 3.28793 | 2 | 6 | 32 | regulation of B cell differentiation |
| GO:0046879 | 0.01670 | 1.52612 | 23 | 34 | 353 | hormone secretion |
| GO:0032940 | 0.01702 | 1.29729 | 68 | 85 | 1028 | secretion by cell |
| GO:0002790 | 0.01712 | 1.38878 | 40 | 54 | 612 | peptide secretion |
| GO:0031397 | 0.01733 | 2.33806 | 5 | 10 | 71 | negative regulation of protein ubiquitination |
| GO:0043900 | 0.01735 | 1.49285 | 26 | 37 | 392 | regulation of multi-organism process |
| GO:0006811 | 0.01743 | 1.24291 | 100 | 121 | 1526 | ion transport |
| GO:0001974 | 0.01743 | 2.65214 | 3 | 8 | 51 | blood vessel remodeling |
| GO:0010823 | 0.01743 | 2.65214 | 3 | 8 | 51 | negative regulation of mitochondrion organization |
| GO:0030041 | 0.01744 | 1.78587 | 11 | 19 | 171 | actin filament polymerization |
| GO:0030858 | 0.01763 | 2.46786 | 4 | 9 | 61 | positive regulation of epithelial cell differentiation |
| GO:0032677 | 0.01763 | 2.46786 | 4 | 9 | 61 | regulation of interleukin-8 production |
| GO:2001238 | 0.01763 | 2.46786 | 4 | 9 | 61 | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0006241 | 0.01765 | 7.11639 | 1 | 3 | 9 | CTP biosynthetic process |
| GO:0009396 | 0.01765 | 7.11639 | 1 | 3 | 9 | folic acid-containing compound biosynthetic process |
| GO:0016559 | 0.01765 | 7.11639 | 1 | 3 | 9 | peroxisome fission |
| GO:0017062 | 0.01765 | 7.11639 | 1 | 3 | 9 | respiratory chain complex III assembly |
| GO:0031622 | 0.01765 | 7.11639 | 1 | 3 | 9 | positive regulation of fever generation |
| GO:0032471 | 0.01765 | 7.11639 | 1 | 3 | 9 | negative regulation of endoplasmic reticulum calcium ion concentration |
| GO:0034374 | 0.01765 | 7.11639 | 1 | 3 | 9 | low-density lipoprotein particle remodeling |
| GO:0034551 | 0.01765 | 7.11639 | 1 | 3 | 9 | mitochondrial respiratory chain complex III assembly |
| GO:0036363 | 0.01765 | 7.11639 | 1 | 3 | 9 | transforming growth factor beta activation |
| GO:0043569 | 0.01765 | 7.11639 | 1 | 3 | 9 | negative regulation of insulin-like growth factor receptor signaling pathway |
| GO:0046036 | 0.01765 | 7.11639 | 1 | 3 | 9 | CTP metabolic process |
| GO:0046051 | 0.01765 | 7.11639 | 1 | 3 | 9 | UTP metabolic process |
| GO:0060312 | 0.01765 | 7.11639 | 1 | 3 | 9 | regulation of blood vessel remodeling |
| GO:0060426 | 0.01765 | 7.11639 | 1 | 3 | 9 | lung vasculature development |
| GO:2000343 | 0.01765 | 7.11639 | 1 | 3 | 9 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:0032103 | 0.01769 | 1.57771 | 19 | 29 | 292 | positive regulation of response to external stimulus |
| GO:0090257 | 0.01788 | 1.65772 | 15 | 24 | 231 | regulation of muscle system process |
| GO:0000966 | 0.01790 | 4.74606 | 1 | 4 | 16 | RNA 5'-end processing |
| GO:0032957 | 0.01790 | 4.74606 | 1 | 4 | 16 | inositol trisphosphate metabolic process |
| GO:0043518 | 0.01790 | 4.74606 | 1 | 4 | 16 | negative regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:1903019 | 0.01790 | 4.74606 | 1 | 4 | 16 | negative regulation of glycoprotein metabolic process |
| GO:0006936 | 0.01796 | 1.58956 | 18 | 28 | 280 | muscle contraction |
| GO:0009314 | 0.01799 | 1.48859 | 26 | 37 | 393 | response to radiation |
| GO:0032770 | 0.01816 | 3.74814 | 2 | 5 | 24 | positive regulation of monooxygenase activity |
| GO:0034123 | 0.01816 | 3.74814 | 2 | 5 | 24 | positive regulation of toll-like receptor signaling pathway |
| GO:2001057 | 0.01819 | 2.21007 | 5 | 11 | 82 | reactive nitrogen species metabolic process |
| GO:0051259 | 0.01821 | 1.38765 | 40 | 53 | 601 | protein complex oligomerization |
| GO:1902903 | 0.01843 | 1.52386 | 23 | 33 | 343 | regulation of supramolecular fiber organization |
| GO:0030490 | 0.01864 | 2.85023 | 3 | 7 | 42 | maturation of SSU-rRNA |
| GO:1903169 | 0.01870 | 1.83925 | 10 | 17 | 149 | regulation of calcium ion transmembrane transport |
| GO:0043112 | 0.01880 | 1.71488 | 13 | 21 | 196 | receptor metabolic process |
| GO:0030316 | 0.01880 | 2.03866 | 7 | 13 | 104 | osteoclast differentiation |
| GO:0050728 | 0.01925 | 1.87258 | 9 | 16 | 138 | negative regulation of inflammatory response |
| GO:0002673 | 0.01946 | 2.42118 | 4 | 9 | 62 | regulation of acute inflammatory response |
| GO:0071479 | 0.01946 | 2.42118 | 4 | 9 | 62 | cellular response to ionizing radiation |
| GO:0009887 | 0.01951 | 1.28634 | 69 | 86 | 1048 | animal organ morphogenesis |
| GO:0010556 | 0.01956 | 1.16747 | 213 | 241 | 3242 | regulation of macromolecule biosynthetic process |
| GO:0043270 | 0.01964 | 1.54965 | 20 | 30 | 307 | positive regulation of ion transport |
| GO:0001936 | 0.01971 | 1.91191 | 8 | 15 | 127 | regulation of endothelial cell proliferation |
| GO:0010632 | 0.01976 | 1.66046 | 15 | 23 | 221 | regulation of epithelial cell migration |
| GO:0002573 | 0.01981 | 1.68143 | 14 | 22 | 209 | myeloid leukocyte differentiation |
| GO:0007015 | 0.01999 | 1.47594 | 26 | 37 | 396 | actin filament organization |
| GO:0046474 | 0.02021 | 2.01641 | 7 | 13 | 105 | glycerophospholipid biosynthetic process |
| GO:2000379 | 0.02021 | 2.01641 | 7 | 13 | 105 | positive regulation of reactive oxygen species metabolic process |
| GO:0002262 | 0.02057 | 1.75106 | 11 | 19 | 174 | myeloid cell homeostasis |
| GO:0006886 | 0.02062 | 1.30822 | 58 | 74 | 887 | intracellular protein transport |
| GO:0031347 | 0.02062 | 1.38530 | 38 | 51 | 579 | regulation of defense response |
| GO:0032272 | 0.02074 | 2.26363 | 5 | 10 | 73 | negative regulation of protein polymerization |
| GO:0051271 | 0.02127 | 1.53840 | 20 | 30 | 309 | negative regulation of cellular component movement |
| GO:0002521 | 0.02143 | 1.39122 | 36 | 49 | 554 | leukocyte differentiation |
| GO:0002335 | 0.02151 | 3.56057 | 2 | 5 | 25 | mature B cell differentiation |
| GO:0006925 | 0.02151 | 3.56057 | 2 | 5 | 25 | inflammatory cell apoptotic process |
| GO:0010742 | 0.02151 | 3.56057 | 2 | 5 | 25 | macrophage derived foam cell differentiation |
| GO:1902230 | 0.02151 | 3.56057 | 2 | 5 | 25 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0045620 | 0.02163 | 2.53404 | 3 | 8 | 53 | negative regulation of lymphocyte differentiation |
| GO:0061383 | 0.02163 | 2.53404 | 3 | 8 | 53 | trabecula morphogenesis |
| GO:0120162 | 0.02173 | 2.06263 | 6 | 12 | 95 | positive regulation of cold-induced thermogenesis |
| GO:2001022 | 0.02173 | 2.06263 | 6 | 12 | 95 | positive regulation of response to DNA damage stimulus |
| GO:0045017 | 0.02175 | 1.84221 | 9 | 16 | 140 | glycerolipid biosynthetic process |
| GO:0033032 | 0.02200 | 3.05280 | 2 | 6 | 34 | regulation of myeloid cell apoptotic process |
| GO:1903427 | 0.02200 | 3.05280 | 2 | 6 | 34 | negative regulation of reactive oxygen species biosynthetic process |
| GO:2000108 | 0.02200 | 3.05280 | 2 | 6 | 34 | positive regulation of leukocyte apoptotic process |
| GO:0006516 | 0.02222 | 4.38078 | 1 | 4 | 17 | glycoprotein catabolic process |
| GO:0034656 | 0.02222 | 4.38078 | 1 | 4 | 17 | nucleobase-containing small molecule catabolic process |
| GO:0051000 | 0.02222 | 4.38078 | 1 | 4 | 17 | positive regulation of nitric-oxide synthase activity |
| GO:1902547 | 0.02222 | 4.38078 | 1 | 4 | 17 | regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:0006809 | 0.02261 | 2.22816 | 5 | 10 | 74 | nitric oxide biosynthetic process |
| GO:0051881 | 0.02261 | 2.22816 | 5 | 10 | 74 | regulation of mitochondrial membrane potential |
| GO:0120036 | 0.02268 | 1.23307 | 98 | 117 | 1485 | plasma membrane bounded cell projection organization |
| GO:0050678 | 0.02305 | 1.49451 | 23 | 33 | 349 | regulation of epithelial cell proliferation |
| GO:0010634 | 0.02309 | 1.82739 | 9 | 16 | 141 | positive regulation of epithelial cell migration |
| GO:0045639 | 0.02340 | 2.03798 | 6 | 12 | 96 | positive regulation of myeloid cell differentiation |
| GO:0010594 | 0.02360 | 1.78483 | 10 | 17 | 153 | regulation of endothelial cell migration |
| GO:0032757 | 0.02365 | 2.69591 | 3 | 7 | 44 | positive regulation of interleukin-8 production |
| GO:0045581 | 0.02365 | 2.69591 | 3 | 7 | 44 | negative regulation of T cell differentiation |
| GO:0000480 | 0.02371 | 14.22608 | 0 | 2 | 4 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0002188 | 0.02371 | 14.22608 | 0 | 2 | 4 | translation reinitiation |
| GO:0002538 | 0.02371 | 14.22608 | 0 | 2 | 4 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0006244 | 0.02371 | 14.22608 | 0 | 2 | 4 | pyrimidine nucleotide catabolic process |
| GO:0006269 | 0.02371 | 14.22608 | 0 | 2 | 4 | DNA replication, synthesis of RNA primer |
| GO:0007412 | 0.02371 | 14.22608 | 0 | 2 | 4 | axon target recognition |
| GO:0009189 | 0.02371 | 14.22608 | 0 | 2 | 4 | deoxyribonucleoside diphosphate biosynthetic process |
| GO:0009223 | 0.02371 | 14.22608 | 0 | 2 | 4 | pyrimidine deoxyribonucleotide catabolic process |
| GO:0018364 | 0.02371 | 14.22608 | 0 | 2 | 4 | peptidyl-glutamine methylation |
| GO:0019243 | 0.02371 | 14.22608 | 0 | 2 | 4 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione |
| GO:0035962 | 0.02371 | 14.22608 | 0 | 2 | 4 | response to interleukin-13 |
| GO:0035963 | 0.02371 | 14.22608 | 0 | 2 | 4 | cellular response to interleukin-13 |
| GO:0042494 | 0.02371 | 14.22608 | 0 | 2 | 4 | detection of bacterial lipoprotein |
| GO:0042776 | 0.02371 | 14.22608 | 0 | 2 | 4 | mitochondrial ATP synthesis coupled proton transport |
| GO:0043328 | 0.02371 | 14.22608 | 0 | 2 | 4 | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
| GO:0046102 | 0.02371 | 14.22608 | 0 | 2 | 4 | inosine metabolic process |
| GO:0051596 | 0.02371 | 14.22608 | 0 | 2 | 4 | methylglyoxal catabolic process |
| GO:0060686 | 0.02371 | 14.22608 | 0 | 2 | 4 | negative regulation of prostatic bud formation |
| GO:0061054 | 0.02371 | 14.22608 | 0 | 2 | 4 | dermatome development |
| GO:0061181 | 0.02371 | 14.22608 | 0 | 2 | 4 | regulation of chondrocyte development |
| GO:0061183 | 0.02371 | 14.22608 | 0 | 2 | 4 | regulation of dermatome development |
| GO:0061622 | 0.02371 | 14.22608 | 0 | 2 | 4 | glycolytic process through glucose-1-phosphate |
| GO:0061727 | 0.02371 | 14.22608 | 0 | 2 | 4 | methylglyoxal catabolic process to lactate |
| GO:0071042 | 0.02371 | 14.22608 | 0 | 2 | 4 | nuclear polyadenylation-dependent mRNA catabolic process |
| GO:0071047 | 0.02371 | 14.22608 | 0 | 2 | 4 | polyadenylation-dependent mRNA catabolic process |
| GO:0071724 | 0.02371 | 14.22608 | 0 | 2 | 4 | response to diacyl bacterial lipopeptide |
| GO:0071726 | 0.02371 | 14.22608 | 0 | 2 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0086017 | 0.02371 | 14.22608 | 0 | 2 | 4 | Purkinje myocyte action potential |
| GO:0099538 | 0.02371 | 14.22608 | 0 | 2 | 4 | synaptic signaling via neuropeptide |
| GO:1901069 | 0.02371 | 14.22608 | 0 | 2 | 4 | guanosine-containing compound catabolic process |
| GO:1901509 | 0.02371 | 14.22608 | 0 | 2 | 4 | regulation of endothelial tube morphogenesis |
| GO:1902512 | 0.02371 | 14.22608 | 0 | 2 | 4 | positive regulation of apoptotic DNA fragmentation |
| GO:1902730 | 0.02371 | 14.22608 | 0 | 2 | 4 | positive regulation of proteoglycan biosynthetic process |
| GO:1903225 | 0.02371 | 14.22608 | 0 | 2 | 4 | negative regulation of endodermal cell differentiation |
| GO:2000097 | 0.02371 | 14.22608 | 0 | 2 | 4 | regulation of smooth muscle cell-matrix adhesion |
| GO:2000504 | 0.02371 | 14.22608 | 0 | 2 | 4 | positive regulation of blood vessel remodeling |
| GO:0034250 | 0.02383 | 1.86178 | 9 | 15 | 130 | positive regulation of cellular amide metabolic process |
| GO:0048016 | 0.02398 | 2.47883 | 4 | 8 | 54 | inositol phosphate-mediated signaling |
| GO:0002176 | 0.02400 | 6.09948 | 1 | 3 | 10 | male germ cell proliferation |
| GO:0006000 | 0.02400 | 6.09948 | 1 | 3 | 10 | fructose metabolic process |
| GO:0006995 | 0.02400 | 6.09948 | 1 | 3 | 10 | cellular response to nitrogen starvation |
| GO:0009209 | 0.02400 | 6.09948 | 1 | 3 | 10 | pyrimidine ribonucleoside triphosphate biosynthetic process |
| GO:0009221 | 0.02400 | 6.09948 | 1 | 3 | 10 | pyrimidine deoxyribonucleotide biosynthetic process |
| GO:0009650 | 0.02400 | 6.09948 | 1 | 3 | 10 | UV protection |
| GO:0031620 | 0.02400 | 6.09948 | 1 | 3 | 10 | regulation of fever generation |
| GO:0034145 | 0.02400 | 6.09948 | 1 | 3 | 10 | positive regulation of toll-like receptor 4 signaling pathway |
| GO:0043173 | 0.02400 | 6.09948 | 1 | 3 | 10 | nucleotide salvage |
| GO:0043562 | 0.02400 | 6.09948 | 1 | 3 | 10 | cellular response to nitrogen levels |
| GO:0043928 | 0.02400 | 6.09948 | 1 | 3 | 10 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay |
| GO:0046485 | 0.02400 | 6.09948 | 1 | 3 | 10 | ether lipid metabolic process |
| GO:0047484 | 0.02400 | 6.09948 | 1 | 3 | 10 | regulation of response to osmotic stress |
| GO:0070391 | 0.02400 | 6.09948 | 1 | 3 | 10 | response to lipoteichoic acid |
| GO:0071223 | 0.02400 | 6.09948 | 1 | 3 | 10 | cellular response to lipoteichoic acid |
| GO:1903431 | 0.02400 | 6.09948 | 1 | 3 | 10 | positive regulation of cell maturation |
| GO:1904667 | 0.02400 | 6.09948 | 1 | 3 | 10 | negative regulation of ubiquitin protein ligase activity |
| GO:2001034 | 0.02400 | 6.09948 | 1 | 3 | 10 | positive regulation of double-strand break repair via nonhomologous end joining |
| GO:0030030 | 0.02429 | 1.22616 | 101 | 120 | 1531 | cell projection organization |
| GO:0007292 | 0.02450 | 1.81280 | 9 | 16 | 142 | female gamete generation |
| GO:0048872 | 0.02483 | 1.51637 | 21 | 30 | 313 | homeostasis of number of cells |
| GO:0003015 | 0.02516 | 1.63726 | 14 | 22 | 214 | heart process |
| GO:0002082 | 0.02522 | 3.39086 | 2 | 5 | 26 | regulation of oxidative phosphorylation |
| GO:0010460 | 0.02522 | 3.39086 | 2 | 5 | 26 | positive regulation of heart rate |
| GO:0033158 | 0.02522 | 3.39086 | 2 | 5 | 26 | regulation of protein import into nucleus, translocation |
| GO:0042104 | 0.02522 | 3.39086 | 2 | 5 | 26 | positive regulation of activated T cell proliferation |
| GO:0045730 | 0.02522 | 3.39086 | 2 | 5 | 26 | respiratory burst |
| GO:0045738 | 0.02522 | 3.39086 | 2 | 5 | 26 | negative regulation of DNA repair |
| GO:0090077 | 0.02522 | 3.39086 | 2 | 5 | 26 | foam cell differentiation |
| GO:0045926 | 0.02550 | 1.55044 | 18 | 27 | 276 | negative regulation of growth |
| GO:0030036 | 0.02559 | 1.34841 | 42 | 55 | 640 | actin cytoskeleton organization |
| GO:0043436 | 0.02563 | 1.28774 | 61 | 76 | 924 | oxoacid metabolic process |
| GO:0003254 | 0.02647 | 2.62485 | 3 | 7 | 45 | regulation of membrane depolarization |
| GO:0043029 | 0.02647 | 2.62485 | 3 | 7 | 45 | T cell homeostasis |
| GO:0002548 | 0.02650 | 2.42598 | 4 | 8 | 55 | monocyte chemotaxis |
| GO:0046173 | 0.02650 | 2.42598 | 4 | 8 | 55 | polyol biosynthetic process |
| GO:0042116 | 0.02673 | 2.16044 | 5 | 10 | 76 | macrophage activation |
| GO:0050772 | 0.02702 | 1.99040 | 6 | 12 | 98 | positive regulation of axonogenesis |
| GO:0021954 | 0.02709 | 2.06419 | 6 | 11 | 87 | central nervous system neuron development |
| GO:1905954 | 0.02709 | 2.06419 | 6 | 11 | 87 | positive regulation of lipid localization |
| GO:0018904 | 0.02712 | 4.06768 | 1 | 4 | 18 | ether metabolic process |
| GO:0030502 | 0.02712 | 4.06768 | 1 | 4 | 18 | negative regulation of bone mineralization |
| GO:0045324 | 0.02712 | 4.06768 | 1 | 4 | 18 | late endosome to vacuole transport |
| GO:0050650 | 0.02712 | 4.06768 | 1 | 4 | 18 | chondroitin sulfate proteoglycan biosynthetic process |
| GO:0060572 | 0.02712 | 4.06768 | 1 | 4 | 18 | morphogenesis of an epithelial bud |
| GO:0060707 | 0.02712 | 4.06768 | 1 | 4 | 18 | trophoblast giant cell differentiation |
| GO:0060712 | 0.02712 | 4.06768 | 1 | 4 | 18 | spongiotrophoblast layer development |
| GO:0070886 | 0.02712 | 4.06768 | 1 | 4 | 18 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0071605 | 0.02712 | 4.06768 | 1 | 4 | 18 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.02712 | 4.06768 | 1 | 4 | 18 | regulation of monocyte chemotactic protein-1 production |
| GO:0106058 | 0.02712 | 4.06768 | 1 | 4 | 18 | positive regulation of calcineurin-mediated signaling |
| GO:1901028 | 0.02712 | 4.06768 | 1 | 4 | 18 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GO:2001032 | 0.02712 | 4.06768 | 1 | 4 | 18 | regulation of double-strand break repair via nonhomologous end joining |
| GO:0045786 | 0.02800 | 1.41418 | 29 | 40 | 445 | negative regulation of cell cycle |
| GO:0034220 | 0.02813 | 1.29219 | 57 | 71 | 860 | ion transmembrane transport |
| GO:0014068 | 0.02816 | 2.25086 | 4 | 9 | 66 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0045428 | 0.02816 | 2.25086 | 4 | 9 | 66 | regulation of nitric oxide biosynthetic process |
| GO:0051784 | 0.02816 | 2.25086 | 4 | 9 | 66 | negative regulation of nuclear division |
| GO:0043086 | 0.02849 | 1.33142 | 44 | 57 | 671 | negative regulation of catalytic activity |
| GO:0016601 | 0.02852 | 2.84901 | 2 | 6 | 36 | Rac protein signal transduction |
| GO:0045987 | 0.02852 | 2.84901 | 2 | 6 | 36 | positive regulation of smooth muscle contraction |
| GO:0046470 | 0.02852 | 2.84901 | 2 | 6 | 36 | phosphatidylcholine metabolic process |
| GO:0051172 | 0.02875 | 1.18219 | 146 | 168 | 2222 | negative regulation of nitrogen compound metabolic process |
| GO:0110053 | 0.02876 | 1.56034 | 17 | 25 | 254 | regulation of actin filament organization |
| GO:0046209 | 0.02897 | 2.12809 | 5 | 10 | 77 | nitric oxide metabolic process |
| GO:0051279 | 0.02897 | 2.12809 | 5 | 10 | 77 | regulation of release of sequestered calcium ion into cytosol |
| GO:0042770 | 0.02919 | 2.03729 | 6 | 11 | 88 | signal transduction in response to DNA damage |
| GO:0098655 | 0.02921 | 1.32919 | 44 | 57 | 672 | cation transmembrane transport |
| GO:0000460 | 0.02933 | 3.23658 | 2 | 5 | 27 | maturation of 5.8S rRNA |
| GO:0006195 | 0.02933 | 3.23658 | 2 | 5 | 27 | purine nucleotide catabolic process |
| GO:0032925 | 0.02933 | 3.23658 | 2 | 5 | 27 | regulation of activin receptor signaling pathway |
| GO:0033687 | 0.02933 | 3.23658 | 2 | 5 | 27 | osteoblast proliferation |
| GO:0045980 | 0.02933 | 3.23658 | 2 | 5 | 27 | negative regulation of nucleotide metabolic process |
| GO:0046639 | 0.02933 | 3.23658 | 2 | 5 | 27 | negative regulation of alpha-beta T cell differentiation |
| GO:0060713 | 0.02933 | 3.23658 | 2 | 5 | 27 | labyrinthine layer morphogenesis |
| GO:0061050 | 0.02933 | 3.23658 | 2 | 5 | 27 | regulation of cell growth involved in cardiac muscle cell development |
| GO:0090200 | 0.02933 | 3.23658 | 2 | 5 | 27 | positive regulation of release of cytochrome c from mitochondria |
| GO:0097345 | 0.02933 | 3.23658 | 2 | 5 | 27 | mitochondrial outer membrane permeabilization |
| GO:0009719 | 0.02938 | 1.22711 | 91 | 109 | 1388 | response to endogenous stimulus |
| GO:0001504 | 0.02951 | 2.55743 | 3 | 7 | 46 | neurotransmitter uptake |
| GO:0006303 | 0.02951 | 2.55743 | 3 | 7 | 46 | double-strand break repair via nonhomologous end joining |
| GO:0002761 | 0.02953 | 1.84966 | 8 | 14 | 122 | regulation of myeloid leukocyte differentiation |
| GO:0048871 | 0.02959 | 1.39548 | 31 | 42 | 473 | multicellular organismal homeostasis |
| GO:0030001 | 0.02998 | 1.29454 | 54 | 68 | 822 | metal ion transport |
| GO:0006260 | 0.03055 | 1.56602 | 16 | 24 | 243 | DNA replication |
| GO:0060047 | 0.03056 | 1.62143 | 14 | 21 | 206 | heart contraction |
| GO:0006029 | 0.03070 | 2.21195 | 4 | 9 | 67 | proteoglycan metabolic process |
| GO:0032637 | 0.03070 | 2.21195 | 4 | 9 | 67 | interleukin-8 production |
| GO:0043412 | 0.03085 | 1.14519 | 235 | 261 | 3571 | macromolecule modification |
| GO:0030038 | 0.03104 | 1.94498 | 7 | 12 | 100 | contractile actin filament bundle assembly |
| GO:0043149 | 0.03104 | 1.94498 | 7 | 12 | 100 | stress fiber assembly |
| GO:0043902 | 0.03109 | 1.69075 | 11 | 18 | 170 | positive regulation of multi-organism process |
| GO:0032956 | 0.03128 | 1.47296 | 22 | 31 | 332 | regulation of actin cytoskeleton organization |
| GO:0034762 | 0.03130 | 1.36301 | 36 | 47 | 541 | regulation of transmembrane transport |
| GO:0006096 | 0.03135 | 2.09670 | 5 | 10 | 78 | glycolytic process |
| GO:0045682 | 0.03135 | 2.09670 | 5 | 10 | 78 | regulation of epidermis development |
| GO:0001682 | 0.03142 | 5.33680 | 1 | 3 | 11 | tRNA 5'-leader removal |
| GO:0009208 | 0.03142 | 5.33680 | 1 | 3 | 11 | pyrimidine ribonucleoside triphosphate metabolic process |
| GO:0010872 | 0.03142 | 5.33680 | 1 | 3 | 11 | regulation of cholesterol esterification |
| GO:0032463 | 0.03142 | 5.33680 | 1 | 3 | 11 | negative regulation of protein homooligomerization |
| GO:0032959 | 0.03142 | 5.33680 | 1 | 3 | 11 | inositol trisphosphate biosynthetic process |
| GO:0035376 | 0.03142 | 5.33680 | 1 | 3 | 11 | sterol import |
| GO:0035999 | 0.03142 | 5.33680 | 1 | 3 | 11 | tetrahydrofolate interconversion |
| GO:0036093 | 0.03142 | 5.33680 | 1 | 3 | 11 | germ cell proliferation |
| GO:0043589 | 0.03142 | 5.33680 | 1 | 3 | 11 | skin morphogenesis |
| GO:0051901 | 0.03142 | 5.33680 | 1 | 3 | 11 | positive regulation of mitochondrial depolarization |
| GO:0070508 | 0.03142 | 5.33680 | 1 | 3 | 11 | cholesterol import |
| GO:1901163 | 0.03142 | 5.33680 | 1 | 3 | 11 | regulation of trophoblast cell migration |
| GO:1902166 | 0.03142 | 5.33680 | 1 | 3 | 11 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:1902231 | 0.03142 | 5.33680 | 1 | 3 | 11 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0046883 | 0.03151 | 1.50491 | 19 | 28 | 294 | regulation of hormone secretion |
| GO:0061458 | 0.03164 | 1.40008 | 30 | 40 | 449 | reproductive system development |
| GO:0010498 | 0.03173 | 1.40619 | 29 | 39 | 436 | proteasomal protein catabolic process |
| GO:0060485 | 0.03181 | 1.52929 | 18 | 26 | 269 | mesenchyme development |
| GO:0006082 | 0.03185 | 1.26971 | 62 | 77 | 948 | organic acid metabolic process |
| GO:0051348 | 0.03185 | 1.55882 | 16 | 24 | 244 | negative regulation of transferase activity |
| GO:0070972 | 0.03208 | 2.32675 | 4 | 8 | 57 | protein localization to endoplasmic reticulum |
| GO:0033365 | 0.03209 | 1.30231 | 50 | 63 | 757 | protein localization to organelle |
| GO:0006464 | 0.03215 | 1.14672 | 224 | 249 | 3400 | cellular protein modification process |
| GO:0036211 | 0.03215 | 1.14672 | 224 | 249 | 3400 | protein modification process |
| GO:0006692 | 0.03221 | 2.75698 | 2 | 6 | 37 | prostanoid metabolic process |
| GO:0006693 | 0.03221 | 2.75698 | 2 | 6 | 37 | prostaglandin metabolic process |
| GO:0033028 | 0.03221 | 2.75698 | 2 | 6 | 37 | myeloid cell apoptotic process |
| GO:0042398 | 0.03221 | 2.75698 | 2 | 6 | 37 | cellular modified amino acid biosynthetic process |
| GO:0042987 | 0.03221 | 2.75698 | 2 | 6 | 37 | amyloid precursor protein catabolic process |
| GO:0048265 | 0.03221 | 2.75698 | 2 | 6 | 37 | response to pain |
| GO:1905209 | 0.03221 | 2.75698 | 2 | 6 | 37 | positive regulation of cardiocyte differentiation |
| GO:0042476 | 0.03239 | 1.87323 | 7 | 13 | 112 | odontogenesis |
| GO:0090305 | 0.03239 | 1.87323 | 7 | 13 | 112 | nucleic acid phosphodiester bond hydrolysis |
| GO:0022409 | 0.03244 | 1.57226 | 15 | 23 | 232 | positive regulation of cell-cell adhesion |
| GO:0016075 | 0.03261 | 3.79633 | 1 | 4 | 19 | rRNA catabolic process |
| GO:0031664 | 0.03261 | 3.79633 | 1 | 4 | 19 | regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0034472 | 0.03261 | 3.79633 | 1 | 4 | 19 | snRNA 3'-end processing |
| GO:0035584 | 0.03261 | 3.79633 | 1 | 4 | 19 | calcium-mediated signaling using intracellular calcium source |
| GO:0043094 | 0.03261 | 3.79633 | 1 | 4 | 19 | cellular metabolic compound salvage |
| GO:0000060 | 0.03277 | 2.49338 | 3 | 7 | 47 | protein import into nucleus, translocation |
| GO:0042088 | 0.03277 | 2.49338 | 3 | 7 | 47 | T-helper 1 type immune response |
| GO:0051353 | 0.03277 | 2.49338 | 3 | 7 | 47 | positive regulation of oxidoreductase activity |
| GO:0032880 | 0.03295 | 1.26144 | 65 | 80 | 991 | regulation of protein localization |
| GO:0051258 | 0.03308 | 1.52295 | 18 | 26 | 270 | protein polymerization |
| GO:0033137 | 0.03383 | 3.09572 | 2 | 5 | 28 | negative regulation of peptidyl-serine phosphorylation |
| GO:0045992 | 0.03383 | 3.09572 | 2 | 5 | 28 | negative regulation of embryonic development |
| GO:0051307 | 0.03383 | 3.09572 | 2 | 5 | 28 | meiotic chromosome separation |
| GO:0071480 | 0.03383 | 3.09572 | 2 | 5 | 28 | cellular response to gamma radiation |
| GO:1903319 | 0.03383 | 3.09572 | 2 | 5 | 28 | positive regulation of protein maturation |
| GO:2000727 | 0.03383 | 3.09572 | 2 | 5 | 28 | positive regulation of cardiac muscle cell differentiation |
| GO:0006757 | 0.03386 | 2.06622 | 5 | 10 | 79 | ATP generation from ADP |
| GO:0038034 | 0.03386 | 2.06622 | 5 | 10 | 79 | signal transduction in absence of ligand |
| GO:0097192 | 0.03386 | 2.06622 | 5 | 10 | 79 | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0006937 | 0.03429 | 1.72992 | 10 | 16 | 148 | regulation of muscle contraction |
| GO:0008016 | 0.03437 | 1.66864 | 11 | 18 | 172 | regulation of heart contraction |
| GO:0018209 | 0.03454 | 1.46901 | 21 | 30 | 322 | peptidyl-serine modification |
| GO:0000375 | 0.03458 | 1.54464 | 16 | 24 | 246 | RNA splicing, via transesterification reactions |
| GO:0000377 | 0.03458 | 1.54464 | 16 | 24 | 246 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| GO:0000398 | 0.03458 | 1.54464 | 16 | 24 | 246 | mRNA splicing, via spliceosome |
| GO:0014706 | 0.03475 | 1.39545 | 29 | 39 | 439 | striated muscle tissue development |
| GO:0043161 | 0.03503 | 1.43046 | 25 | 34 | 374 | proteasome-mediated ubiquitin-dependent protein catabolic process |
| GO:0042136 | 0.03546 | 1.90158 | 7 | 12 | 102 | neurotransmitter biosynthetic process |
| GO:0043628 | 0.03619 | 2.67070 | 2 | 6 | 38 | ncRNA 3'-end processing |
| GO:0072595 | 0.03619 | 2.67070 | 2 | 6 | 38 | maintenance of protein localization in organelle |
| GO:0006399 | 0.03622 | 1.68505 | 11 | 17 | 161 | tRNA metabolic process |
| GO:0002720 | 0.03627 | 2.43245 | 3 | 7 | 48 | positive regulation of cytokine production involved in immune response |
| GO:0002762 | 0.03627 | 2.43245 | 3 | 7 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:2001239 | 0.03627 | 2.43245 | 3 | 7 | 48 | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0006970 | 0.03651 | 2.03661 | 5 | 10 | 80 | response to osmotic stress |
| GO:0015672 | 0.03669 | 1.38285 | 30 | 40 | 454 | monovalent inorganic cation transport |
| GO:1904062 | 0.03705 | 1.45888 | 21 | 30 | 324 | regulation of cation transmembrane transport |
| GO:0002901 | 0.03781 | 9.48362 | 0 | 2 | 5 | mature B cell apoptotic process |
| GO:0002905 | 0.03781 | 9.48362 | 0 | 2 | 5 | regulation of mature B cell apoptotic process |
| GO:0002906 | 0.03781 | 9.48362 | 0 | 2 | 5 | negative regulation of mature B cell apoptotic process |
| GO:0003199 | 0.03781 | 9.48362 | 0 | 2 | 5 | endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:0009211 | 0.03781 | 9.48362 | 0 | 2 | 5 | pyrimidine deoxyribonucleoside triphosphate metabolic process |
| GO:0010991 | 0.03781 | 9.48362 | 0 | 2 | 5 | negative regulation of SMAD protein complex assembly |
| GO:0031118 | 0.03781 | 9.48362 | 0 | 2 | 5 | rRNA pseudouridine synthesis |
| GO:0033499 | 0.03781 | 9.48362 | 0 | 2 | 5 | galactose catabolic process via UDP-galactose |
| GO:0033864 | 0.03781 | 9.48362 | 0 | 2 | 5 | positive regulation of NAD(P)H oxidase activity |
| GO:0035934 | 0.03781 | 9.48362 | 0 | 2 | 5 | corticosterone secretion |
| GO:0035964 | 0.03781 | 9.48362 | 0 | 2 | 5 | COPI-coated vesicle budding |
| GO:0040031 | 0.03781 | 9.48362 | 0 | 2 | 5 | snRNA modification |
| GO:0042483 | 0.03781 | 9.48362 | 0 | 2 | 5 | negative regulation of odontogenesis |
| GO:0042536 | 0.03781 | 9.48362 | 0 | 2 | 5 | negative regulation of tumor necrosis factor biosynthetic process |
| GO:0042701 | 0.03781 | 9.48362 | 0 | 2 | 5 | progesterone secretion |
| GO:0051103 | 0.03781 | 9.48362 | 0 | 2 | 5 | DNA ligation involved in DNA repair |
| GO:0060057 | 0.03781 | 9.48362 | 0 | 2 | 5 | apoptotic process involved in mammary gland involution |
| GO:0060058 | 0.03781 | 9.48362 | 0 | 2 | 5 | positive regulation of apoptotic process involved in mammary gland involution |
| GO:0060264 | 0.03781 | 9.48362 | 0 | 2 | 5 | regulation of respiratory burst involved in inflammatory response |
| GO:0061073 | 0.03781 | 9.48362 | 0 | 2 | 5 | ciliary body morphogenesis |
| GO:0070487 | 0.03781 | 9.48362 | 0 | 2 | 5 | monocyte aggregation |
| GO:0071038 | 0.03781 | 9.48362 | 0 | 2 | 5 | nuclear polyadenylation-dependent tRNA catabolic process |
| GO:0071455 | 0.03781 | 9.48362 | 0 | 2 | 5 | cellular response to hyperoxia |
| GO:0086029 | 0.03781 | 9.48362 | 0 | 2 | 5 | Purkinje myocyte to ventricular cardiac muscle cell signaling |
| GO:0086068 | 0.03781 | 9.48362 | 0 | 2 | 5 | Purkinje myocyte to ventricular cardiac muscle cell communication |
| GO:0106049 | 0.03781 | 9.48362 | 0 | 2 | 5 | regulation of cellular response to osmotic stress |
| GO:1901164 | 0.03781 | 9.48362 | 0 | 2 | 5 | negative regulation of trophoblast cell migration |
| GO:1902218 | 0.03781 | 9.48362 | 0 | 2 | 5 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:1903519 | 0.03781 | 9.48362 | 0 | 2 | 5 | regulation of mammary gland involution |
| GO:1903521 | 0.03781 | 9.48362 | 0 | 2 | 5 | positive regulation of mammary gland involution |
| GO:1903626 | 0.03781 | 9.48362 | 0 | 2 | 5 | positive regulation of DNA catabolic process |
| GO:1905446 | 0.03781 | 9.48362 | 0 | 2 | 5 | regulation of mitochondrial ATP synthesis coupled electron transport |
| GO:1990564 | 0.03781 | 9.48362 | 0 | 2 | 5 | protein polyufmylation |
| GO:1990592 | 0.03781 | 9.48362 | 0 | 2 | 5 | protein K69-linked ufmylation |
| GO:2000224 | 0.03781 | 9.48362 | 0 | 2 | 5 | regulation of testosterone biosynthetic process |
| GO:2000324 | 0.03781 | 9.48362 | 0 | 2 | 5 | positive regulation of glucocorticoid receptor signaling pathway |
| GO:0002687 | 0.03792 | 1.74004 | 9 | 15 | 138 | positive regulation of leukocyte migration |
| GO:0071495 | 0.03805 | 1.22806 | 79 | 95 | 1207 | cellular response to endogenous stimulus |
| GO:0030336 | 0.03807 | 1.51357 | 17 | 25 | 261 | negative regulation of cell migration |
| GO:0006733 | 0.03809 | 1.67335 | 11 | 17 | 162 | oxidoreduction coenzyme metabolic process |
| GO:0051494 | 0.03811 | 1.70394 | 10 | 16 | 150 | negative regulation of cytoskeleton organization |
| GO:0010817 | 0.03813 | 1.34706 | 35 | 46 | 535 | regulation of hormone levels |
| GO:0060986 | 0.03841 | 2.23529 | 4 | 8 | 59 | endocrine hormone secretion |
| GO:0002313 | 0.03870 | 3.55889 | 1 | 4 | 20 | mature B cell differentiation involved in immune response |
| GO:0010560 | 0.03870 | 3.55889 | 1 | 4 | 20 | positive regulation of glycoprotein biosynthetic process |
| GO:0016226 | 0.03870 | 3.55889 | 1 | 4 | 20 | iron-sulfur cluster assembly |
| GO:0031163 | 0.03870 | 3.55889 | 1 | 4 | 20 | metallo-sulfur cluster assembly |
| GO:0044819 | 0.03870 | 3.55889 | 1 | 4 | 20 | mitotic G1/S transition checkpoint |
| GO:0045623 | 0.03870 | 3.55889 | 1 | 4 | 20 | negative regulation of T-helper cell differentiation |
| GO:0046131 | 0.03870 | 3.55889 | 1 | 4 | 20 | pyrimidine ribonucleoside metabolic process |
| GO:0046653 | 0.03870 | 3.55889 | 1 | 4 | 20 | tetrahydrofolate metabolic process |
| GO:2000010 | 0.03870 | 3.55889 | 1 | 4 | 20 | positive regulation of protein localization to cell surface |
| GO:0002931 | 0.03874 | 2.96660 | 2 | 5 | 29 | response to ischemia |
| GO:0045672 | 0.03874 | 2.96660 | 2 | 5 | 29 | positive regulation of osteoclast differentiation |
| GO:0050654 | 0.03874 | 2.96660 | 2 | 5 | 29 | chondroitin sulfate proteoglycan metabolic process |
| GO:1901222 | 0.03875 | 1.93633 | 6 | 11 | 92 | regulation of NIK/NF-kappaB signaling |
| GO:0071214 | 0.03896 | 1.48408 | 19 | 27 | 287 | cellular response to abiotic stimulus |
| GO:0104004 | 0.03896 | 1.48408 | 19 | 27 | 287 | cellular response to environmental stimulus |
| GO:0000724 | 0.03896 | 1.81788 | 8 | 13 | 115 | double-strand break repair via homologous recombination |
| GO:0000725 | 0.03896 | 1.81788 | 8 | 13 | 115 | recombinational repair |
| GO:1903321 | 0.03929 | 2.00783 | 5 | 10 | 81 | negative regulation of protein modification by small protein conjugation or removal |
| GO:0040013 | 0.03968 | 1.44889 | 21 | 30 | 326 | negative regulation of locomotion |
| GO:0002016 | 0.03989 | 4.74361 | 1 | 3 | 12 | regulation of blood volume by renin-angiotensin |
| GO:0034350 | 0.03989 | 4.74361 | 1 | 3 | 12 | regulation of glial cell apoptotic process |
| GO:0035933 | 0.03989 | 4.74361 | 1 | 3 | 12 | glucocorticoid secretion |
| GO:0036295 | 0.03989 | 4.74361 | 1 | 3 | 12 | cellular response to increased oxygen levels |
| GO:0061450 | 0.03989 | 4.74361 | 1 | 3 | 12 | trophoblast cell migration |
| GO:0097049 | 0.03989 | 4.74361 | 1 | 3 | 12 | motor neuron apoptotic process |
| GO:2000341 | 0.03989 | 4.74361 | 1 | 3 | 12 | regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:0032941 | 0.04001 | 2.37442 | 3 | 7 | 49 | secretion by tissue |
| GO:0050850 | 0.04001 | 2.37442 | 3 | 7 | 49 | positive regulation of calcium-mediated signaling |
| GO:0001822 | 0.04003 | 1.49202 | 18 | 26 | 275 | kidney development |
| GO:2000146 | 0.04003 | 1.49202 | 18 | 26 | 275 | negative regulation of cell motility |
| GO:0071478 | 0.04013 | 1.69124 | 10 | 16 | 151 | cellular response to radiation |
| GO:0072523 | 0.04048 | 2.58965 | 3 | 6 | 39 | purine-containing compound catabolic process |
| GO:0070727 | 0.04072 | 1.19213 | 108 | 126 | 1648 | cellular macromolecule localization |
| GO:0042176 | 0.04116 | 1.41708 | 24 | 33 | 366 | regulation of protein catabolic process |
| GO:0002685 | 0.04116 | 1.60496 | 12 | 19 | 188 | regulation of leukocyte migration |
| GO:0002791 | 0.04133 | 1.35273 | 33 | 43 | 498 | regulation of peptide secretion |
| GO:0048608 | 0.04143 | 1.37444 | 29 | 39 | 445 | reproductive structure development |
| GO:0006898 | 0.04160 | 1.56181 | 14 | 21 | 213 | receptor-mediated endocytosis |
| GO:0010770 | 0.04166 | 1.62610 | 12 | 18 | 176 | positive regulation of cell morphogenesis involved in differentiation |
| GO:0002763 | 0.04187 | 2.19221 | 4 | 8 | 60 | positive regulation of myeloid leukocyte differentiation |
| GO:0042632 | 0.04222 | 1.97985 | 5 | 10 | 82 | cholesterol homeostasis |
| GO:0042866 | 0.04222 | 1.97985 | 5 | 10 | 82 | pyruvate biosynthetic process |
| GO:0034101 | 0.04223 | 1.71204 | 9 | 15 | 140 | erythrocyte homeostasis |
| GO:0051896 | 0.04223 | 1.67873 | 10 | 16 | 152 | regulation of protein kinase B signaling |
| GO:1990845 | 0.04223 | 1.67873 | 10 | 16 | 152 | adaptive thermogenesis |
| GO:0008154 | 0.04237 | 1.57759 | 13 | 20 | 201 | actin polymerization or depolymerization |
| GO:0019751 | 0.04291 | 1.83999 | 7 | 12 | 105 | polyol metabolic process |
| GO:0097756 | 0.04291 | 1.83999 | 7 | 12 | 105 | negative regulation of blood vessel diameter |
| GO:0050708 | 0.04355 | 1.36271 | 30 | 40 | 460 | regulation of protein secretion |
| GO:0060537 | 0.04355 | 1.36271 | 30 | 40 | 460 | muscle tissue development |
| GO:0033138 | 0.04383 | 1.78276 | 8 | 13 | 117 | positive regulation of peptidyl-serine phosphorylation |
| GO:0042107 | 0.04383 | 1.78276 | 8 | 13 | 117 | cytokine metabolic process |
| GO:0034613 | 0.04399 | 1.18854 | 108 | 125 | 1639 | cellular protein localization |
| GO:0002825 | 0.04407 | 2.84780 | 2 | 5 | 30 | regulation of T-helper 1 type immune response |
| GO:0044319 | 0.04407 | 2.84780 | 2 | 5 | 30 | wound healing, spreading of cells |
| GO:0090505 | 0.04407 | 2.84780 | 2 | 5 | 30 | epiboly involved in wound healing |
| GO:1902110 | 0.04407 | 2.84780 | 2 | 5 | 30 | positive regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:0006511 | 0.04410 | 1.32725 | 36 | 47 | 554 | ubiquitin-dependent protein catabolic process |
| GO:0002367 | 0.04427 | 1.88949 | 6 | 11 | 94 | cytokine production involved in immune response |
| GO:0030510 | 0.04427 | 1.88949 | 6 | 11 | 94 | regulation of BMP signaling pathway |
| GO:0051304 | 0.04427 | 1.88949 | 6 | 11 | 94 | chromosome separation |
| GO:1903530 | 0.04431 | 1.26974 | 53 | 65 | 799 | regulation of secretion by cell |
| GO:0002700 | 0.04450 | 1.69838 | 9 | 15 | 141 | regulation of production of molecular mediator of immune response |
| GO:0106106 | 0.04450 | 1.69838 | 9 | 15 | 141 | cold-induced thermogenesis |
| GO:0120161 | 0.04450 | 1.69838 | 9 | 15 | 141 | regulation of cold-induced thermogenesis |
| GO:0009628 | 0.04496 | 1.23693 | 67 | 81 | 1021 | response to abiotic stimulus |
| GO:0045823 | 0.04508 | 2.51337 | 3 | 6 | 40 | positive regulation of heart contraction |
| GO:0055092 | 0.04530 | 1.95264 | 5 | 10 | 83 | sterol homeostasis |
| GO:0006691 | 0.04540 | 3.34939 | 1 | 4 | 21 | leukotriene metabolic process |
| GO:0010743 | 0.04540 | 3.34939 | 1 | 4 | 21 | regulation of macrophage derived foam cell differentiation |
| GO:0032332 | 0.04540 | 3.34939 | 1 | 4 | 21 | positive regulation of chondrocyte differentiation |
| GO:0042533 | 0.04540 | 3.34939 | 1 | 4 | 21 | tumor necrosis factor biosynthetic process |
| GO:0042534 | 0.04540 | 3.34939 | 1 | 4 | 21 | regulation of tumor necrosis factor biosynthetic process |
| GO:0015914 | 0.04552 | 2.15074 | 4 | 8 | 61 | phospholipid transport |
| GO:0090501 | 0.04552 | 2.15074 | 4 | 8 | 61 | RNA phosphodiester bond hydrolysis |
| GO:0090559 | 0.04552 | 2.15074 | 4 | 8 | 61 | regulation of membrane permeability |
| GO:1902305 | 0.04552 | 2.15074 | 4 | 8 | 61 | regulation of sodium ion transmembrane transport |
| GO:0045619 | 0.04570 | 1.60562 | 12 | 18 | 178 | regulation of lymphocyte differentiation |
| GO:2000112 | 0.04607 | 1.13760 | 208 | 230 | 3156 | regulation of cellular macromolecule biosynthetic process |
| GO:0061572 | 0.04626 | 1.62812 | 11 | 17 | 166 | actin filament bundle organization |
| GO:0008584 | 0.04642 | 1.76570 | 8 | 13 | 118 | male gonad development |
| GO:0010605 | 0.04671 | 1.15107 | 167 | 187 | 2533 | negative regulation of macromolecule metabolic process |
| GO:0010466 | 0.04673 | 1.50672 | 16 | 23 | 241 | negative regulation of peptidase activity |
| GO:0051928 | 0.04681 | 1.72146 | 9 | 14 | 130 | positive regulation of calcium ion transport |
| GO:0046394 | 0.04687 | 1.41569 | 23 | 31 | 344 | carboxylic acid biosynthetic process |
| GO:0010595 | 0.04722 | 1.86691 | 6 | 11 | 95 | positive regulation of endothelial cell migration |
| GO:0006935 | 0.04814 | 1.31392 | 38 | 48 | 571 | chemotaxis |
| GO:0006302 | 0.04816 | 1.55165 | 13 | 20 | 204 | double-strand break repair |
| GO:1903708 | 0.04816 | 1.55165 | 13 | 20 | 204 | positive regulation of hemopoiesis |
| GO:0045933 | 0.04821 | 2.26629 | 3 | 7 | 51 | positive regulation of muscle contraction |
| GO:0046902 | 0.04821 | 2.26629 | 3 | 7 | 51 | regulation of mitochondrial membrane permeability |
| GO:0016053 | 0.04838 | 1.41112 | 23 | 31 | 345 | organic acid biosynthetic process |
| GO:0048145 | 0.04844 | 1.80108 | 7 | 12 | 107 | regulation of fibroblast proliferation |
| GO:0051209 | 0.04844 | 1.80108 | 7 | 12 | 107 | release of sequestered calcium ion into cytosol |
| GO:0001818 | 0.04856 | 1.49977 | 16 | 23 | 242 | negative regulation of cytokine production |
| GO:0046546 | 0.04912 | 1.74896 | 8 | 13 | 119 | development of primary male sexual characteristics |
| GO:0019058 | 0.04913 | 1.56756 | 13 | 19 | 192 | viral life cycle |
| GO:0009060 | 0.04934 | 2.00402 | 5 | 9 | 73 | aerobic respiration |
| GO:0051145 | 0.04934 | 2.00402 | 5 | 9 | 73 | smooth muscle cell differentiation |
| GO:0007093 | 0.04938 | 1.70667 | 9 | 14 | 131 | mitotic cell cycle checkpoint |
| GO:0001660 | 0.04939 | 4.26905 | 1 | 3 | 13 | fever generation |
| GO:0010561 | 0.04939 | 4.26905 | 1 | 3 | 13 | negative regulation of glycoprotein biosynthetic process |
| GO:0031145 | 0.04939 | 4.26905 | 1 | 3 | 13 | anaphase-promoting complex-dependent catabolic process |
| GO:0032926 | 0.04939 | 4.26905 | 1 | 3 | 13 | negative regulation of activin receptor signaling pathway |
| GO:0033690 | 0.04939 | 4.26905 | 1 | 3 | 13 | positive regulation of osteoblast proliferation |
| GO:0034116 | 0.04939 | 4.26905 | 1 | 3 | 13 | positive regulation of heterotypic cell-cell adhesion |
| GO:0035721 | 0.04939 | 4.26905 | 1 | 3 | 13 | intraciliary retrograde transport |
| GO:0036296 | 0.04939 | 4.26905 | 1 | 3 | 13 | response to increased oxygen levels |
| GO:0038065 | 0.04939 | 4.26905 | 1 | 3 | 13 | collagen-activated signaling pathway |
| GO:0042454 | 0.04939 | 4.26905 | 1 | 3 | 13 | ribonucleoside catabolic process |
| GO:0042574 | 0.04939 | 4.26905 | 1 | 3 | 13 | retinal metabolic process |
| GO:0042891 | 0.04939 | 4.26905 | 1 | 3 | 13 | antibiotic transport |
| GO:0042994 | 0.04939 | 4.26905 | 1 | 3 | 13 | cytoplasmic sequestering of transcription factor |
| GO:0043508 | 0.04939 | 4.26905 | 1 | 3 | 13 | negative regulation of JUN kinase activity |
| GO:0043517 | 0.04939 | 4.26905 | 1 | 3 | 13 | positive regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0045136 | 0.04939 | 4.26905 | 1 | 3 | 13 | development of secondary sexual characteristics |
| GO:0046185 | 0.04939 | 4.26905 | 1 | 3 | 13 | aldehyde catabolic process |
| GO:0060394 | 0.04939 | 4.26905 | 1 | 3 | 13 | negative regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0071295 | 0.04939 | 4.26905 | 1 | 3 | 13 | cellular response to vitamin |
| GO:0072567 | 0.04939 | 4.26905 | 1 | 3 | 13 | chemokine (C-X-C motif) ligand 2 production |
| GO:1904181 | 0.04939 | 4.26905 | 1 | 3 | 13 | positive regulation of membrane depolarization |
| GO:2000833 | 0.04939 | 4.26905 | 1 | 3 | 13 | positive regulation of steroid hormone secretion |
| GO:0034142 | 0.04980 | 2.73814 | 2 | 5 | 31 | toll-like receptor 4 signaling pathway |
| GO:0034661 | 0.04980 | 2.73814 | 2 | 5 | 31 | ncRNA catabolic process |
| GO:0090504 | 0.04980 | 2.73814 | 2 | 5 | 31 | epiboly |
| GO:1901797 | 0.04980 | 2.73814 | 2 | 5 | 31 | negative regulation of signal transduction by p53 class mediator |
| GO:0016073 | 0.04999 | 2.44145 | 3 | 6 | 41 | snRNA metabolic process |
| GO:0045981 | 0.04999 | 2.44145 | 3 | 6 | 41 | positive regulation of nucleotide metabolic process |
| GO:0051281 | 0.04999 | 2.44145 | 3 | 6 | 41 | positive regulation of release of sequestered calcium ion into cytosol |
| GO:1900544 | 0.04999 | 2.44145 | 3 | 6 | 41 | positive regulation of purine nucleotide metabolic process |
| GO:1903672 | 0.04999 | 2.44145 | 3 | 6 | 41 | positive regulation of sprouting angiogenesis |